| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | HSPG2 FRAS1 VWF MATN3 LAMA3 LAMA5 LAMC1 FBLN1 FBN1 PRG3 NID1 LTBP2 LTBP4 MUC5AC FBN3 | 3.58e-13 | 188 | 118 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 MATN3 FSTL5 NOTCH2NLA FLG2 NOTCH2NLC LRP1B F7 SVEP1 JAG2 FBLN1 PPP2R3A FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 1.04e-11 | 749 | 118 | 24 | GO:0005509 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NR2E3 ZBTB16 ZNF577 ZNF175 ZNF549 GSX2 ZBTB41 NR6A1 ZNF354C ZNF551 KLF2 NFE2L3 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 NOTCH1 NOTCH2 NOTCH4 ZNF304 | 7.49e-06 | 1412 | 118 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | integrin binding | 9.56e-06 | 175 | 118 | 8 | GO:0005178 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NR2E3 ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 NR6A1 ZNF354C ZNF551 KLF2 NFE2L3 ZNF250 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 NOTCH1 NOTCH2 NOTCH4 ZNF304 | 1.61e-05 | 1271 | 118 | 21 | GO:0000987 |
| GeneOntologyMolecularFunction | Notch binding | 1.83e-05 | 27 | 118 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 FRAS1 VWF MATN3 LAMA3 LAMA5 LAMC1 FLG2 FBLN1 FBN1 PRG3 NID1 LTBP2 LTBP4 MUC5AC FBN3 | 7.06e-05 | 891 | 118 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | NR2E3 ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 NR6A1 ZNF354C ZNF551 KLF2 NFE2L3 ZNF250 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF304 | 3.64e-04 | 1244 | 118 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NR2E3 ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 NR6A1 ZNF354C ZNF551 KLF2 NFE2L3 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF304 | 8.98e-04 | 1459 | 118 | 19 | GO:0000977 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 9.21e-04 | 73 | 118 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activator activity | 1.25e-03 | 36 | 118 | 3 | GO:0030296 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.62e-03 | 85 | 118 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.20e-03 | 12 | 118 | 2 | GO:0030023 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | PAPPA2 HSPG2 FRAS1 NR2E3 NSD2 WNT2 NAGLU LAMA3 NTNG1 LAMA5 PEX7 LAMC1 GSX2 PLXND1 GCNT4 JAG2 DZANK1 PPP2R3A LRP4 LTBP3 FST NOTCH1 NOTCH2 | 5.23e-07 | 1269 | 116 | 23 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 3.71e-06 | 114 | 116 | 7 | GO:0008593 | |
| GeneOntologyBiologicalProcess | epidermis morphogenesis | 5.88e-06 | 46 | 116 | 5 | GO:0048730 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 6.49e-06 | 124 | 116 | 7 | GO:0007229 | |
| GeneOntologyBiologicalProcess | vasculature development | HSPG2 WNT2 NAGLU RAPGEF1 PLXND1 EPGN ITGA7 ZNF354C SVEP1 CD160 KLF2 LLGL2 EGF NOTCH1 NOTCH2 NOTCH4 EPHA1 ZNF304 | 7.68e-06 | 969 | 116 | 18 | GO:0001944 |
| GeneOntologyBiologicalProcess | kidney development | FRAS1 ZBTB16 CRLF1 LAMA5 PLXND1 GCNT4 FBN1 LRP4 NID1 NOTCH1 NOTCH2 | 8.21e-06 | 372 | 116 | 11 | GO:0001822 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | FRAS1 WNT2 NAGLU LAMA5 LAMC1 PLXND1 FLG2 JAG2 LLGL2 EGF FST NOTCH1 NOTCH2 NOTCH4 | 1.01e-05 | 619 | 116 | 14 | GO:0002009 |
| GeneOntologyBiologicalProcess | renal system development | FRAS1 ZBTB16 CRLF1 LAMA5 PLXND1 GCNT4 FBN1 LRP4 NID1 NOTCH1 NOTCH2 | 1.16e-05 | 386 | 116 | 11 | GO:0072001 |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 1.19e-05 | 53 | 116 | 5 | GO:0045747 | |
| GeneOntologyBiologicalProcess | circulatory system development | HSPG2 ERBB3 NSD2 WNT2 NAGLU OBSL1 RAPGEF1 PLXND1 EPGN ITGA7 ZNF354C SVEP1 CD160 KLF2 FBN1 LLGL2 EGF NOTCH1 NOTCH2 NOTCH4 EPHA1 ZNF304 | 1.55e-05 | 1442 | 116 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | blood vessel development | HSPG2 WNT2 NAGLU RAPGEF1 PLXND1 EPGN ITGA7 ZNF354C CD160 KLF2 LLGL2 EGF NOTCH1 NOTCH2 NOTCH4 EPHA1 ZNF304 | 1.72e-05 | 929 | 116 | 17 | GO:0001568 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FRAS1 WNT2 NAGLU LAMA5 LAMC1 PLXND1 FLG2 GCNT4 JAG2 LLGL2 EGF FST NOTCH1 NOTCH2 NOTCH4 | 2.03e-05 | 750 | 116 | 15 | GO:0048729 |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 2.50e-05 | 210 | 116 | 8 | GO:0007219 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ERBB3 EPHA6 FSTL5 RAPGEF1 DGKD PTPRU EPGN F7 SVEP1 FBN1 EGF LRP4 LTBP2 LTBP3 FST LTBP4 NOTCH1 NOTCH2 EPHA1 | 3.32e-05 | 1186 | 116 | 19 | GO:0007167 |
| GeneOntologyBiologicalProcess | skeletal system development | PAPPA2 HSPG2 ZBTB16 NSD2 MATN3 LAMA5 PEX7 LECT2 JAG2 FBN1 LTBP3 FST NOTCH2 | 4.29e-05 | 615 | 116 | 13 | GO:0001501 |
| GeneOntologyBiologicalProcess | skin epidermis development | 4.31e-05 | 166 | 116 | 7 | GO:0098773 | |
| GeneOntologyBiologicalProcess | cardiac atrium morphogenesis | 4.35e-05 | 35 | 116 | 4 | GO:0003209 | |
| GeneOntologyBiologicalProcess | eye photoreceptor cell differentiation | 5.34e-05 | 72 | 116 | 5 | GO:0001754 | |
| GeneOntologyBiologicalProcess | hair follicle development | 6.91e-05 | 123 | 116 | 6 | GO:0001942 | |
| GeneOntologyBiologicalProcess | hair follicle morphogenesis | 7.42e-05 | 40 | 116 | 4 | GO:0031069 | |
| GeneOntologyBiologicalProcess | molting cycle process | 7.90e-05 | 126 | 116 | 6 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 7.90e-05 | 126 | 116 | 6 | GO:0022405 | |
| GeneOntologyBiologicalProcess | cardiac atrium development | 9.01e-05 | 42 | 116 | 4 | GO:0003230 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 9.37e-05 | 3 | 116 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.08e-04 | 410 | 116 | 10 | GO:0031589 | |
| GeneOntologyBiologicalProcess | bone development | 1.25e-04 | 264 | 116 | 8 | GO:0060348 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell proliferation | 1.46e-04 | 270 | 116 | 8 | GO:0050679 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.57e-04 | 204 | 116 | 7 | GO:0048592 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 1.87e-04 | 4 | 116 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | HSPG2 NAGLU PLXND1 EPGN ITGA7 ZNF354C CD160 KLF2 EGF NOTCH1 NOTCH2 NOTCH4 EPHA1 ZNF304 | 2.00e-04 | 817 | 116 | 14 | GO:0048514 |
| GeneOntologyBiologicalProcess | molting cycle | 2.06e-04 | 150 | 116 | 6 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 2.06e-04 | 150 | 116 | 6 | GO:0042633 | |
| GeneOntologyBiologicalProcess | photoreceptor cell differentiation | 2.10e-04 | 96 | 116 | 5 | GO:0046530 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by cadherin | 2.14e-04 | 21 | 116 | 3 | GO:2000047 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | HSPG2 ERBB3 ZBTB16 LAMA3 LAMA5 LAMC1 PLXND1 PTPRU CD160 JAG2 FBLN1 NID1 NOTCH1 NOTCH4 EPHA1 | 2.18e-04 | 927 | 116 | 15 | GO:0030155 |
| GeneOntologyBiologicalProcess | epidermis development | 2.79e-04 | 461 | 116 | 10 | GO:0008544 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 2.83e-04 | 377 | 116 | 9 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 2.88e-04 | 378 | 116 | 9 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 2.94e-04 | 379 | 116 | 9 | GO:0045229 | |
| GeneOntologyBiologicalProcess | tube development | HSPG2 CRLF1 WNT2 NAGLU LAMA5 PLXND1 EPGN ITGA7 ZNF354C CD160 KLF2 FBN1 EGF LTBP3 NOTCH1 NOTCH2 NOTCH4 EPHA1 ZNF304 | 2.98e-04 | 1402 | 116 | 19 | GO:0035295 |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 3.33e-04 | 106 | 116 | 5 | GO:0051149 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 3.81e-04 | 236 | 116 | 7 | GO:0061138 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 4.63e-04 | 6 | 116 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | regulation of aorta morphogenesis | 4.63e-04 | 6 | 116 | 2 | GO:1903847 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 4.63e-04 | 6 | 116 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 4.63e-04 | 6 | 116 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 5.12e-04 | 28 | 116 | 3 | GO:0051152 | |
| GeneOntologyBiologicalProcess | epithelium development | FRAS1 CRLF1 WNT2 NAGLU LAMA5 RAPGEF1 LAMC1 PLXND1 FLG2 KLF2 JAG2 PPP2R3A LLGL2 EGF LRP4 FST NOTCH1 NOTCH2 NOTCH4 | 5.32e-04 | 1469 | 116 | 19 | GO:0060429 |
| GeneOntologyBiologicalProcess | tube morphogenesis | HSPG2 WNT2 NAGLU LAMA5 PLXND1 EPGN ITGA7 ZNF354C CD160 KLF2 EGF NOTCH1 NOTCH2 NOTCH4 EPHA1 ZNF304 | 5.59e-04 | 1125 | 116 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | angiogenesis | HSPG2 PLXND1 EPGN ZNF354C CD160 KLF2 EGF NOTCH1 NOTCH2 NOTCH4 EPHA1 ZNF304 | 6.44e-04 | 708 | 116 | 12 | GO:0001525 |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 6.46e-04 | 7 | 116 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 6.47e-04 | 258 | 116 | 7 | GO:0001763 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 7.35e-04 | 344 | 116 | 8 | GO:0060070 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 8.29e-04 | 195 | 116 | 6 | GO:0030178 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 8.74e-04 | 131 | 116 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 8.97e-04 | 198 | 116 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | animal organ regeneration | 1.03e-03 | 79 | 116 | 4 | GO:0031100 | |
| GeneOntologyBiologicalProcess | aorta development | 1.08e-03 | 80 | 116 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 1.10e-03 | 9 | 116 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of artery morphogenesis | 1.10e-03 | 9 | 116 | 2 | GO:1905653 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.16e-03 | 285 | 116 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | HSPG2 WNT2 OBSL1 NTNG1 PLXND1 ITGA7 ZNF354C CD160 KLF2 EGF LRP4 NOTCH1 NOTCH4 EPHA1 ZNF304 | 1.17e-03 | 1090 | 116 | 15 | GO:0022603 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.18e-03 | 286 | 116 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | skin development | 1.24e-03 | 373 | 116 | 8 | GO:0043588 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.28e-03 | 212 | 116 | 6 | GO:0003205 | |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 EPHA6 LAMA3 NTNG1 LAMA5 LAMC1 PLXND1 LRP4 NOTCH1 NOTCH2 | 1.35e-03 | 566 | 116 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 1.37e-03 | 10 | 116 | 2 | GO:2000048 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 LAMB4 FRAS1 VWF ZAN WNT2 MATN3 LAMA3 LAMA5 LAMC1 ADAMTSL3 F7 SVEP1 FBLN1 FBN1 PRG3 MEGF6 ADAMTS20 NID1 LTBP2 LTBP3 LTBP4 MUC5AC FBN3 | 2.39e-13 | 656 | 118 | 24 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 LAMB4 FRAS1 VWF ZAN WNT2 MATN3 LAMA3 LAMA5 LAMC1 ADAMTSL3 F7 SVEP1 FBLN1 FBN1 PRG3 MEGF6 ADAMTS20 NID1 LTBP2 LTBP3 LTBP4 MUC5AC FBN3 | 2.56e-13 | 658 | 118 | 24 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 LAMB4 FRAS1 VWF WNT2 MATN3 LAMA3 LAMA5 LAMC1 F7 FBLN1 FBN1 PRG3 MEGF6 ADAMTS20 NID1 LTBP2 LTBP3 LTBP4 | 1.39e-10 | 530 | 118 | 19 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 3.06e-08 | 122 | 118 | 9 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 2.04e-05 | 10 | 118 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.07e-05 | 59 | 118 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | microfibril | 4.81e-05 | 13 | 118 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | laminin-10 complex | 9.44e-05 | 3 | 118 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 9.44e-05 | 3 | 118 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.88e-04 | 4 | 118 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 1.01e-03 | 35 | 118 | 3 | GO:0005834 | |
| GeneOntologyCellularComponent | side of membrane | VWF CRLF1 NTNG1 ITGA7 ITGAD CRLF2 CD160 SHROOM4 BTN3A3 GLIPR1L1 GNB4 GNB1 GNB2 | 1.34e-03 | 875 | 118 | 13 | GO:0098552 |
| GeneOntologyCellularComponent | GTPase complex | 1.60e-03 | 41 | 118 | 3 | GO:1905360 | |
| GeneOntologyCellularComponent | receptor complex | ERBB3 CRLF1 PLXND1 ITGA7 ITGAD LRP1B CRLF2 NOTCH1 NOTCH2 EPHA1 | 1.69e-03 | 581 | 118 | 10 | GO:0043235 |
| HumanPheno | Abnormality of the elbow | HSPG2 CRLF1 MATN3 OBSL1 ITGA7 JAG2 FBN1 LRP4 LTBP3 GNB1 GNB2 NOTCH2 | 2.14e-06 | 282 | 43 | 12 | HP:0009811 |
| HumanPheno | Mitral atresia | 2.98e-06 | 13 | 43 | 4 | HP:0011560 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | FRAS1 CRLF1 NSD2 MATN3 OBSL1 NTNG1 LAMA5 PEX7 PLXND1 FBN1 LRP4 LTBP2 LTBP3 GNB2 NOTCH1 NOTCH2 | 3.36e-06 | 538 | 43 | 16 | HP:0005927 |
| HumanPheno | Aplasia involving bones of the extremities | HSPG2 FRAS1 CRLF1 NSD2 MATN3 OBSL1 NTNG1 LAMA5 PEX7 PLXND1 NOTCH2NLC FBN1 LRP4 GNB4 LTBP2 LTBP3 GNB2 NOTCH1 NOTCH2 | 3.64e-06 | 759 | 43 | 19 | HP:0009825 |
| HumanPheno | Aplasia/hypoplasia involving bones of the extremities | HSPG2 FRAS1 CRLF1 NSD2 MATN3 OBSL1 NTNG1 LAMA5 PEX7 PLXND1 NOTCH2NLC FBN1 LRP4 GNB4 LTBP2 LTBP3 GNB2 NOTCH1 NOTCH2 | 3.79e-06 | 761 | 43 | 19 | HP:0045060 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | FRAS1 CRLF1 NSD2 MATN3 OBSL1 NTNG1 LAMA5 PEX7 PLXND1 FBN1 LRP4 LTBP2 LTBP3 GNB2 NOTCH1 NOTCH2 | 7.52e-06 | 572 | 43 | 16 | HP:0006496 |
| HumanPheno | Abnormal atrioventricular connection | 9.68e-06 | 17 | 43 | 4 | HP:0011546 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | HSPG2 FRAS1 ERBB3 CRLF1 NSD2 MATN3 PEPD OBSL1 TRMT1 NTNG1 LAMA5 PEX7 PLXND1 ITGA7 NOTCH2NLC LRPPRC FBN1 LRP4 GNB4 LTBP2 LTBP3 GNB2 LTBP4 NOTCH1 NOTCH2 | 9.93e-06 | 1343 | 43 | 25 | HP:0009115 |
| HumanPheno | Aplasia/hypoplasia of the extremities | HSPG2 FRAS1 CRLF1 NSD2 MATN3 OBSL1 NTNG1 LAMA5 PEX7 PLXND1 NOTCH2NLC FBN1 LRP4 GNB4 LTBP2 LTBP3 GNB2 NOTCH1 NOTCH2 | 1.03e-05 | 813 | 43 | 19 | HP:0009815 |
| HumanPheno | Abnormality of the metacarpal bones | 1.38e-05 | 228 | 43 | 10 | HP:0001163 | |
| HumanPheno | Abnormal metacarpal morphology | 1.38e-05 | 228 | 43 | 10 | HP:0005916 | |
| HumanPheno | Abnormal form of the vertebral bodies | HSPG2 NSD2 MATN3 NAGLU OBSL1 LAMA5 PEX7 NOTCH2NLC FBN1 LRP4 LTBP3 NOTCH2 | 1.90e-05 | 348 | 43 | 12 | HP:0003312 |
| HumanPheno | Hypoplastic pubic bone | 1.93e-05 | 20 | 43 | 4 | HP:0003173 | |
| HumanPheno | Aplasia/Hypoplasia of the pubic bone | 2.37e-05 | 21 | 43 | 4 | HP:0009104 | |
| HumanPheno | Abnormal pubic bone morphology | 3.21e-05 | 45 | 43 | 5 | HP:0003172 | |
| HumanPheno | Limited elbow movement | 6.41e-05 | 168 | 43 | 8 | HP:0002996 | |
| HumanPheno | Hypoplastic facial bones | HSPG2 PEPD OBSL1 TRMT1 PEX7 LRPPRC FBN1 LRP4 LTBP3 LTBP4 NOTCH2 | 6.45e-05 | 331 | 43 | 11 | HP:0002692 |
| HumanPheno | Aplasia/Hypoplasia of facial bones | HSPG2 PEPD OBSL1 TRMT1 PEX7 LRPPRC FBN1 LRP4 LTBP3 LTBP4 NOTCH2 | 6.63e-05 | 332 | 43 | 11 | HP:0034261 |
| HumanPheno | Fifth metacarpal with ulnar notch | 6.96e-05 | 2 | 43 | 2 | HP:0005900 | |
| HumanPheno | Calvarial skull defect | 7.78e-05 | 28 | 43 | 4 | HP:0001362 | |
| HumanPheno | Abnormal sternum morphology | HSPG2 FRAS1 NSD2 MATN3 OBSL1 LAMA5 PLXND1 ITGA7 FBN1 LRP4 LTBP2 GNB1 NOTCH2 | 8.92e-05 | 474 | 43 | 13 | HP:0000766 |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | HSPG2 NSD2 MATN3 NTNG1 LAMA5 PEX7 NOTCH2NLC FBN1 LRP4 GNB4 LTBP3 NOTCH1 NOTCH2 | 8.92e-05 | 474 | 43 | 13 | HP:0006493 |
| HumanPheno | Abnormal vertebral morphology | HSPG2 FRAS1 NSD2 MATN3 NAGLU OBSL1 LAMA5 PEX7 NOTCH2NLC FBN1 LRP4 LTBP3 NOTCH2 | 1.08e-04 | 483 | 43 | 13 | HP:0003468 |
| HumanPheno | Malar flattening | 1.36e-04 | 240 | 43 | 9 | HP:0000272 | |
| HumanPheno | Aplasia/Hypoplasia of fingers | FRAS1 NSD2 OBSL1 LAMA5 PLXND1 FBN1 LRP4 LTBP2 GNB2 NOTCH1 NOTCH2 | 1.60e-04 | 366 | 43 | 11 | HP:0006265 |
| HumanPheno | Ovoid vertebral bodies | 1.70e-04 | 34 | 43 | 4 | HP:0003300 | |
| HumanPheno | Abnormal malar bone morphology | 1.80e-04 | 249 | 43 | 9 | HP:0012369 | |
| HumanPheno | Abnormal hand morphology | HSPG2 FRAS1 CRLF1 NSD2 MATN3 OBSL1 LAMA3 NTNG1 LAMA5 PEX7 PLXND1 FBLN1 FBN1 LRP4 LTBP2 LTBP3 GNB1 GNB2 NOTCH1 NOTCH2 | 1.81e-04 | 1082 | 43 | 20 | HP:0005922 |
| HumanPheno | Abnormal zygomatic arch morphology | 1.86e-04 | 250 | 43 | 9 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 1.86e-04 | 250 | 43 | 9 | HP:0010668 | |
| HumanPheno | Abnormal mitral valve morphology | 1.87e-04 | 146 | 43 | 7 | HP:0031477 | |
| HumanPheno | Aplasia/Hypoplasia of the thumb | 2.21e-04 | 150 | 43 | 7 | HP:0009601 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | HSPG2 FRAS1 ERBB3 CRLF1 NSD2 PEPD OBSL1 TRMT1 LAMA5 PEX7 PLXND1 ITGA7 LRPPRC FBN1 LRP4 LTBP3 GNB2 LTBP4 NOTCH2 | 2.26e-04 | 1008 | 43 | 19 | HP:0009122 |
| HumanPheno | Abnormal mitral valve morphology | 2.29e-04 | 257 | 43 | 9 | HP:0001633 | |
| HumanPheno | Aortic valve stenosis | 3.26e-04 | 113 | 43 | 6 | HP:0001650 | |
| HumanPheno | Abnormal lower limb bone morphology | PAPPA2 HSPG2 NSD2 MATN3 OBSL1 NTNG1 LAMA5 PEX7 NOTCH2NLC TG FBLN1 FBN1 LRP4 GNB4 LTBP3 NOTCH1 NOTCH2 | 3.61e-04 | 866 | 43 | 17 | HP:0040069 |
| HumanPheno | Abnormality of upper limb joint | HSPG2 CRLF1 NSD2 MATN3 OBSL1 PLXND1 ITGA7 JAG2 FBLN1 FBN1 LRP4 LTBP3 GNB1 GNB2 NOTCH2 | 3.95e-04 | 705 | 43 | 15 | HP:0009810 |
| HumanPheno | Microspherophakia | 4.13e-04 | 4 | 43 | 2 | HP:0030961 | |
| HumanPheno | Coronal cleft vertebrae | 4.19e-04 | 18 | 43 | 3 | HP:0003417 | |
| HumanPheno | Abnormal upper limb bone morphology | NSD2 MATN3 OBSL1 LAMA5 PEX7 PLXND1 FBLN1 FBN1 LRP4 LTBP3 NOTCH1 NOTCH2 | 4.64e-04 | 484 | 43 | 12 | HP:0040070 |
| HumanPheno | Abnormal hip bone morphology | HSPG2 FRAS1 NSD2 MATN3 PEPD OBSL1 LAMA5 ITGA7 TG SHROOM4 FBLN1 FBN1 LRP4 GNB2 | 6.17e-04 | 653 | 43 | 14 | HP:0003272 |
| HumanPheno | Congenital hip dislocation | 6.36e-04 | 84 | 43 | 5 | HP:0001374 | |
| HumanPheno | Limitation of joint mobility | HSPG2 CRLF1 MATN3 NAGLU ITGA7 JAG2 FBN1 LTBP2 LTBP3 GNB1 GNB2 | 6.80e-04 | 432 | 43 | 11 | HP:0001376 |
| HumanPheno | Iridodonesis | 6.85e-04 | 5 | 43 | 2 | HP:0100693 | |
| HumanPheno | Spherophakia | 6.85e-04 | 5 | 43 | 2 | HP:0034375 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | 6.85e-04 | 298 | 43 | 9 | HP:0006494 | |
| HumanPheno | Abnormal morphology of bones of the upper limbs | NSD2 MATN3 OBSL1 LAMA5 PEX7 PLXND1 FBLN1 FBN1 LRP4 LTBP3 NOTCH1 | 7.35e-04 | 436 | 43 | 11 | HP:0040065 |
| HumanPheno | Limb undergrowth | HSPG2 FRAS1 MATN3 OBSL1 LAMA5 PEX7 NOTCH2NLC FBN1 LRP4 GNB4 LTBP3 | 8.57e-04 | 444 | 43 | 11 | HP:0009826 |
| HumanPheno | Abnormal shoulder morphology | 8.78e-04 | 246 | 43 | 8 | HP:0003043 | |
| MousePheno | abnormal jaw morphology | PAPPA2 HSPG2 FRAS1 NSD2 LAMA3 LAMA5 PLXND1 KLF2 JAG2 CNBP FBLN1 FBN1 LRP4 LTBP3 FST | 2.01e-06 | 530 | 93 | 15 | MP:0000454 |
| MousePheno | aneurysm | 3.24e-06 | 35 | 93 | 5 | MP:0003279 | |
| MousePheno | abnormal basement membrane morphology | 6.40e-06 | 40 | 93 | 5 | MP:0004272 | |
| MousePheno | abnormal viscerocranium morphology | PAPPA2 HSPG2 FRAS1 NSD2 LAMA3 LAMA5 PLXND1 KLF2 JAG2 CNBP FBLN1 FBN1 LRP4 LTBP3 FST | 7.89e-06 | 593 | 93 | 15 | MP:0005274 |
| MousePheno | internal hemorrhage | HSPG2 FRAS1 VWF LAMC1 PLXND1 ITGA7 F7 KLF2 DZANK1 FBLN1 FBN1 NOTCH1 | 9.43e-06 | 387 | 93 | 12 | MP:0001634 |
| MousePheno | limbs/digits/tail phenotype | PAPPA2 HSPG2 FRAS1 ZBTB16 MATN3 PEPD LAMA5 LAMC1 NR6A1 ITGA7 ADAMTSL3 SVEP1 TG JAG2 FBN1 LRP4 ADAMTS20 PAPPA XAF1 FST NOTCH2 EPHA1 | 1.94e-05 | 1258 | 93 | 22 | MP:0005371 |
| MousePheno | abnormal axial skeleton morphology | PAPPA2 HSPG2 FRAS1 ZBTB16 NSD2 NAGLU LAMA3 LAMA5 PLXND1 NR6A1 ITGA7 ADAMTSL3 KLF2 JAG2 CNBP FBLN1 FBN1 LRP4 XAF1 LTBP3 FST LTBP4 NOTCH1 NOTCH2 | 2.02e-05 | 1458 | 93 | 24 | MP:0002114 |
| MousePheno | abnormal hindlimb morphology | PAPPA2 HSPG2 FRAS1 ZBTB16 MATN3 PEPD LAMC1 ADAMTSL3 TG FBN1 LRP4 PAPPA FST NOTCH2 | 2.56e-05 | 576 | 93 | 14 | MP:0000556 |
| MousePheno | absent kidney | 2.61e-05 | 53 | 93 | 5 | MP:0000520 | |
| MousePheno | syndactyly | 3.53e-05 | 93 | 93 | 6 | MP:0000564 | |
| MousePheno | abnormal capillary morphology | 3.53e-05 | 93 | 93 | 6 | MP:0003658 | |
| MousePheno | abnormal ureteric bud morphology | 3.73e-05 | 57 | 93 | 5 | MP:0006032 | |
| MousePheno | abnormal limb morphology | PAPPA2 HSPG2 FRAS1 ZBTB16 MATN3 PEPD LAMA5 LAMC1 ITGA7 ADAMTSL3 SVEP1 TG JAG2 FBN1 LRP4 ADAMTS20 PAPPA FST NOTCH2 | 3.82e-05 | 1028 | 93 | 19 | MP:0002109 |
| MousePheno | abnormal vertebral column morphology | PAPPA2 HSPG2 FRAS1 ZBTB16 PLXND1 NR6A1 ITGA7 JAG2 FBLN1 FBN1 LRP4 XAF1 LTBP3 FST NOTCH1 NOTCH2 | 5.65e-05 | 787 | 93 | 16 | MP:0004703 |
| MousePheno | abnormal renal glomerular capsule morphology | 7.76e-05 | 107 | 93 | 6 | MP:0002828 | |
| MousePheno | abnormal craniofacial bone morphology | PAPPA2 HSPG2 FRAS1 NSD2 NAGLU LAMA3 LAMA5 PLXND1 KLF2 JAG2 CNBP FBLN1 FBN1 LRP4 LTBP3 FST | 1.01e-04 | 827 | 93 | 16 | MP:0002116 |
| MousePheno | abnormal urinary bladder physiology | 1.02e-04 | 37 | 93 | 4 | MP:0010386 | |
| MousePheno | hemorrhage | HSPG2 FRAS1 VWF RAPGEF1 LAMC1 PLXND1 ITGA7 F7 KLF2 DZANK1 FBLN1 FBN1 NOTCH1 NOTCH2 | 1.19e-04 | 664 | 93 | 14 | MP:0001914 |
| MousePheno | abnormal kidney vasculature morphology | 1.23e-04 | 73 | 93 | 5 | MP:0000530 | |
| MousePheno | abnormal aorta morphology | 1.25e-04 | 225 | 93 | 8 | MP:0000272 | |
| MousePheno | abnormal ascending aorta and coronary artery attachment | 1.31e-04 | 3 | 93 | 2 | MP:0010472 | |
| MousePheno | impaired branching involved in ureteric bud morphogenesis | 1.54e-04 | 41 | 93 | 4 | MP:0004936 | |
| MousePheno | abnormal respiration | HSPG2 FRAS1 ERBB3 LAMA3 GSX2 DGKD JAG2 FBLN1 FBN1 LRP4 GNB1 FST LTBP4 | 1.57e-04 | 598 | 93 | 13 | MP:0001943 |
| MousePheno | abnormal craniofacial morphology | PAPPA2 HSPG2 FRAS1 NSD2 NAGLU LAMA3 LAMA5 GSX2 PLXND1 NR6A1 F7 KLF2 JAG2 CNBP FBLN1 FBN1 LRP4 LTBP3 GNB1 FST NOTCH1 | 2.13e-04 | 1372 | 93 | 21 | MP:0000428 |
| MousePheno | craniofacial phenotype | PAPPA2 HSPG2 FRAS1 NSD2 NAGLU LAMA3 LAMA5 GSX2 PLXND1 NR6A1 F7 KLF2 JAG2 CNBP FBLN1 FBN1 LRP4 LTBP3 GNB1 FST NOTCH1 | 2.13e-04 | 1372 | 93 | 21 | MP:0005382 |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 2.22e-04 | 45 | 93 | 4 | MP:0010981 | |
| MousePheno | neonatal lethality | CRLF1 NSD2 WNT2 PEX7 LAMC1 GSX2 DGKD PLXND1 F7 JAG2 CNBP FBLN1 LRP4 FST NOTCH2 | 2.38e-04 | 799 | 93 | 15 | MP:0002058 |
| MousePheno | abnormal appendicular skeleton morphology | PAPPA2 HSPG2 FRAS1 ZBTB16 MATN3 PEPD ADAMTSL3 TG JAG2 FBN1 LRP4 PAPPA LTBP3 FST LTBP4 NOTCH2 | 2.55e-04 | 896 | 93 | 16 | MP:0009250 |
| MousePheno | thick apical ectodermal ridge | 2.60e-04 | 4 | 93 | 2 | MP:0001678 | |
| MousePheno | abnormal glomerular capillary morphology | 2.63e-04 | 47 | 93 | 4 | MP:0011320 | |
| MousePheno | abnormal pelvic girdle bone morphology | 2.81e-04 | 87 | 93 | 5 | MP:0004509 | |
| MousePheno | abnormal kidney capillary morphology | 2.86e-04 | 48 | 93 | 4 | MP:0011310 | |
| MousePheno | abnormal cranium morphology | PAPPA2 HSPG2 FRAS1 NSD2 LAMA3 LAMA5 PLXND1 KLF2 JAG2 CNBP FBLN1 FBN1 LRP4 LTBP3 FST | 2.87e-04 | 813 | 93 | 15 | MP:0000438 |
| MousePheno | abnormal aorta wall morphology | 3.35e-04 | 50 | 93 | 4 | MP:0009866 | |
| MousePheno | abnormal tail morphology | 3.40e-04 | 403 | 93 | 10 | MP:0002111 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 3.48e-04 | 21 | 93 | 3 | MP:0011453 | |
| MousePheno | osteoarthritis | 3.48e-04 | 21 | 93 | 3 | MP:0003560 | |
| MousePheno | abnormal limb long bone morphology | PAPPA2 HSPG2 ZBTB16 MATN3 PEPD ADAMTSL3 TG JAG2 FBN1 LRP4 PAPPA NOTCH2 | 3.72e-04 | 568 | 93 | 12 | MP:0011504 |
| MousePheno | decreased length of long bones | 3.82e-04 | 409 | 93 | 10 | MP:0004686 | |
| MousePheno | abnormal ascending aorta morphology | 4.01e-04 | 22 | 93 | 3 | MP:0009867 | |
| MousePheno | perinatal lethality | HSPG2 ERBB3 CRLF1 NSD2 WNT2 PEX7 LAMC1 GSX2 DGKD PLXND1 F7 JAG2 CNBP FBLN1 LRP4 GNB1 FST NOTCH2 | 4.07e-04 | 1130 | 93 | 18 | MP:0002081 |
| MousePheno | kidney microaneurysm | 4.32e-04 | 5 | 93 | 2 | MP:0010451 | |
| MousePheno | abnormal blood circulation | HSPG2 FRAS1 ERBB3 VWF RAPGEF1 LAMC1 PLXND1 ITGA7 F7 KLF2 DZANK1 FBLN1 FBN1 NOTCH1 NOTCH2 | 4.33e-04 | 845 | 93 | 15 | MP:0002128 |
| MousePheno | short tibia | 4.75e-04 | 274 | 93 | 8 | MP:0002764 | |
| MousePheno | abnormal limb bone morphology | PAPPA2 HSPG2 ZBTB16 MATN3 PEPD ADAMTSL3 TG JAG2 FBN1 LRP4 PAPPA NOTCH2 | 5.00e-04 | 587 | 93 | 12 | MP:0002115 |
| MousePheno | abnormal long bone morphology | PAPPA2 HSPG2 ZBTB16 MATN3 PEPD ADAMTSL3 TG JAG2 FBN1 LRP4 PAPPA LTBP3 NOTCH2 | 5.14e-04 | 676 | 93 | 13 | MP:0003723 |
| MousePheno | abnormal craniofacial development | 5.16e-04 | 425 | 93 | 10 | MP:0003935 | |
| MousePheno | abnormal extracellular matrix morphology | 5.35e-04 | 100 | 93 | 5 | MP:0013258 | |
| MousePheno | disproportionate dwarf | 5.54e-04 | 57 | 93 | 4 | MP:0002427 | |
| MousePheno | increased Schwann cell number | 6.45e-04 | 6 | 93 | 2 | MP:0010742 | |
| MousePheno | ectopic digits | 6.45e-04 | 6 | 93 | 2 | MP:0000568 | |
| MousePheno | abnormal embryonic neuroepithelium morphology | 6.69e-04 | 105 | 93 | 5 | MP:0004261 | |
| MousePheno | abnormal tooth development | 7.60e-04 | 108 | 93 | 5 | MP:0000116 | |
| MousePheno | cyanosis | 7.67e-04 | 226 | 93 | 7 | MP:0001575 | |
| MousePheno | abnormal respiratory system physiology | HSPG2 FRAS1 ERBB3 WNT2 LAMA3 GSX2 DGKD CRLF2 JAG2 FBLN1 FBN1 LRP4 GNB1 FST LTBP4 | 8.05e-04 | 897 | 93 | 15 | MP:0002133 |
| MousePheno | decreased fetal size | 8.29e-04 | 229 | 93 | 7 | MP:0004200 | |
| MousePheno | abnormal urinary system development | 8.60e-04 | 111 | 93 | 5 | MP:0003942 | |
| MousePheno | abnormal tibia morphology | 8.64e-04 | 375 | 93 | 9 | MP:0000558 | |
| MousePheno | fused metatarsal bones | 9.00e-04 | 7 | 93 | 2 | MP:0004642 | |
| MousePheno | abnormal systemic artery morphology | 9.37e-04 | 304 | 93 | 8 | MP:0011655 | |
| MousePheno | decreased respiration | 9.43e-04 | 170 | 93 | 6 | MP:0014274 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 9.66e-04 | 381 | 93 | 9 | MP:0003857 | |
| MousePheno | abnormal vertebrae morphology | HSPG2 FRAS1 ZBTB16 PLXND1 JAG2 FBN1 XAF1 LTBP3 FST NOTCH1 NOTCH2 | 9.79e-04 | 546 | 93 | 11 | MP:0000137 |
| MousePheno | small lung | 1.01e-03 | 115 | 93 | 5 | MP:0003641 | |
| MousePheno | abnormal fetal size | 1.01e-03 | 237 | 93 | 7 | MP:0004198 | |
| MousePheno | abnormal heart valve physiology | 1.02e-03 | 30 | 93 | 3 | MP:0011926 | |
| MousePheno | abnormal lung size | 1.06e-03 | 174 | 93 | 6 | MP:0004881 | |
| MousePheno | abnormal cochlear hair cell number | 1.08e-03 | 68 | 93 | 4 | MP:0004406 | |
| MousePheno | abnormal fetal growth/weight/body size | 1.11e-03 | 312 | 93 | 8 | MP:0004197 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 1.20e-03 | 70 | 93 | 4 | MP:0011497 | |
| MousePheno | abnormal podocyte morphology | 1.20e-03 | 70 | 93 | 4 | MP:0005326 | |
| MousePheno | abnormal blood vessel morphology | HSPG2 FRAS1 WNT2 NAGLU PEPD TRMT1 LAMA5 RAPGEF1 LAMC1 PLXND1 ITGA7 KLF2 FBLN1 FBN1 LLGL2 NID1 LTBP4 NOTCH1 NOTCH2 NOTCH4 | 1.41e-03 | 1472 | 93 | 20 | MP:0001614 |
| MousePheno | increased aorta wall thickness | 1.53e-03 | 9 | 93 | 2 | MP:0010996 | |
| MousePheno | subcutaneous hemorrhage | 1.53e-03 | 9 | 93 | 2 | MP:0031152 | |
| MousePheno | abnormal aorta tunica adventitia morphology | 1.53e-03 | 9 | 93 | 2 | MP:0009871 | |
| MousePheno | abnormal oxygen level | 1.58e-03 | 256 | 93 | 7 | MP:0001574 | |
| Domain | EGF-like_CS | HSPG2 LAMB4 ZAN MATN3 NOTCH2NLA LAMA3 NTNG1 LAMA5 LAMC1 EPGN NOTCH2NLC LRP1B F7 SVEP1 MEP1A JAG2 FBLN1 FBN1 EGF MEGF6 CNTNAP4 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 EPHA1 | 4.87e-31 | 261 | 118 | 31 | IPR013032 |
| Domain | EGF | HSPG2 FRAS1 ZAN MATN3 NOTCH2NLA LAMA3 NTNG1 LAMA5 LAMC1 EPGN NOTCH2NLC LRP1B F7 SVEP1 MEP1A JAG2 FBLN1 FBN1 EGF MEGF6 CNTNAP4 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 5.40e-31 | 235 | 118 | 30 | SM00181 |
| Domain | EGF_2 | HSPG2 LAMB4 ZAN MATN3 NOTCH2NLA LAMA3 NTNG1 LAMA5 LAMC1 EPGN NOTCH2NLC LRP1B F7 SVEP1 MEP1A JAG2 FBLN1 FBN1 EGF MEGF6 CNTNAP4 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 EPHA1 | 7.88e-31 | 265 | 118 | 31 | PS01186 |
| Domain | EGF-like_dom | HSPG2 FRAS1 ZAN MATN3 NOTCH2NLA LAMA3 NTNG1 LAMA5 LAMC1 EPGN NOTCH2NLC LRP1B F7 SVEP1 MEP1A JAG2 FBLN1 FBN1 EGF MEGF6 CNTNAP4 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 3.22e-30 | 249 | 118 | 30 | IPR000742 |
| Domain | EGF_1 | HSPG2 LAMB4 ZAN NOTCH2NLA LAMA3 NTNG1 LAMA5 LAMC1 EPGN NOTCH2NLC LRP1B F7 SVEP1 MEP1A JAG2 FBLN1 FBN1 EGF MEGF6 CNTNAP4 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 1.83e-28 | 255 | 118 | 29 | PS00022 |
| Domain | Growth_fac_rcpt_ | HSPG2 FRAS1 ERBB3 EPHA6 MATN3 LAMA3 LAMA5 LAMC1 LRP1B SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 EPHA1 | 2.05e-28 | 156 | 118 | 25 | IPR009030 |
| Domain | EGF_3 | HSPG2 ZAN MATN3 NOTCH2NLA NTNG1 EPGN NOTCH2NLC LRP1B F7 SVEP1 MEP1A JAG2 FBLN1 FBN1 EGF MEGF6 CNTNAP4 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 3.26e-25 | 235 | 118 | 26 | PS50026 |
| Domain | EGF_CA | HSPG2 MATN3 NOTCH2NLA NOTCH2NLC LRP1B F7 SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 1.23e-24 | 122 | 118 | 21 | SM00179 |
| Domain | EGF_CA | MATN3 NOTCH2NLA NOTCH2NLC LRP1B SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 1.38e-24 | 86 | 118 | 19 | PF07645 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 MATN3 NOTCH2NLA NOTCH2NLC LRP1B F7 SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 1.76e-24 | 124 | 118 | 21 | IPR001881 |
| Domain | EGF | HSPG2 ZAN MATN3 NOTCH2NLA EPGN NOTCH2NLC LRP1B F7 SVEP1 MEP1A JAG2 EGF MEGF6 CNTNAP4 LRP4 NID1 LTBP2 FBN3 NOTCH1 NOTCH2 NOTCH4 | 2.51e-24 | 126 | 118 | 21 | PF00008 |
| Domain | EGF_Ca-bd_CS | NOTCH2NLA NOTCH2NLC LRP1B F7 SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 1.67e-23 | 97 | 118 | 19 | IPR018097 |
| Domain | EGF_CA | NOTCH2NLA NOTCH2NLC LRP1B F7 SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 2.54e-23 | 99 | 118 | 19 | PS01187 |
| Domain | ASX_HYDROXYL | NOTCH2NLA NOTCH2NLC LRP1B F7 SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 3.11e-23 | 100 | 118 | 19 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NOTCH2NLA NOTCH2NLC LRP1B F7 SVEP1 JAG2 FBLN1 FBN1 EGF MEGF6 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 NOTCH1 NOTCH2 NOTCH4 | 1.02e-22 | 106 | 118 | 19 | IPR000152 |
| Domain | TB_dom | 4.63e-12 | 9 | 118 | 6 | IPR017878 | |
| Domain | TB | 4.63e-12 | 9 | 118 | 6 | PS51364 | |
| Domain | hEGF | 5.58e-12 | 28 | 118 | 8 | PF12661 | |
| Domain | TB | 1.92e-10 | 7 | 118 | 5 | PF00683 | |
| Domain | Notch_dom | 1.92e-10 | 7 | 118 | 5 | IPR000800 | |
| Domain | Notch | 1.92e-10 | 7 | 118 | 5 | PF00066 | |
| Domain | NL | 1.92e-10 | 7 | 118 | 5 | SM00004 | |
| Domain | cEGF | 2.00e-10 | 26 | 118 | 7 | PF12662 | |
| Domain | cEGF | 2.00e-10 | 26 | 118 | 7 | IPR026823 | |
| Domain | - | 5.10e-10 | 8 | 118 | 5 | 3.90.290.10 | |
| Domain | ConA-like_dom | PAPPA2 HSPG2 ZAN NBEAL1 LAMA3 LAMA5 PTPRU SVEP1 MEP1A BTN3A3 CNTNAP4 PAPPA TRIM50 | 1.31e-09 | 219 | 118 | 13 | IPR013320 |
| Domain | EGF_Lam | 1.95e-09 | 35 | 118 | 7 | SM00180 | |
| Domain | Laminin_EGF | 1.95e-09 | 35 | 118 | 7 | PF00053 | |
| Domain | Laminin_EGF | 3.60e-09 | 38 | 118 | 7 | IPR002049 | |
| Domain | EGF_LAM_2 | 2.94e-08 | 30 | 118 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 2.94e-08 | 30 | 118 | 6 | PS01248 | |
| Domain | Laminin_N | 3.82e-08 | 16 | 118 | 5 | IPR008211 | |
| Domain | LamNT | 3.82e-08 | 16 | 118 | 5 | SM00136 | |
| Domain | LAMININ_NTER | 3.82e-08 | 16 | 118 | 5 | PS51117 | |
| Domain | Laminin_N | 3.82e-08 | 16 | 118 | 5 | PF00055 | |
| Domain | KRAB | ZNF577 ZNF175 ZNF549 ZNF354C ZNF551 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 6.05e-08 | 358 | 118 | 14 | PS50805 |
| Domain | KRAB | ZNF577 ZNF175 ZNF549 ZNF354C ZNF551 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 6.05e-08 | 358 | 118 | 14 | PF01352 |
| Domain | KRAB | ZNF577 ZNF175 ZNF549 ZNF354C ZNF551 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 8.78e-08 | 369 | 118 | 14 | SM00349 |
| Domain | KRAB | ZNF577 ZNF175 ZNF549 ZNF354C ZNF551 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 9.08e-08 | 370 | 118 | 14 | IPR001909 |
| Domain | VWC_out | 1.00e-07 | 19 | 118 | 5 | SM00215 | |
| Domain | LAMININ_IVA | 1.04e-07 | 8 | 118 | 4 | PS51115 | |
| Domain | Laminin_B | 1.04e-07 | 8 | 118 | 4 | PF00052 | |
| Domain | LamB | 1.04e-07 | 8 | 118 | 4 | SM00281 | |
| Domain | Laminin_IV | 1.04e-07 | 8 | 118 | 4 | IPR000034 | |
| Domain | - | 1.54e-07 | 95 | 118 | 8 | 2.60.120.200 | |
| Domain | Notch | 9.79e-07 | 4 | 118 | 3 | IPR008297 | |
| Domain | NODP | 9.79e-07 | 4 | 118 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 9.79e-07 | 4 | 118 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 9.79e-07 | 4 | 118 | 3 | IPR010660 | |
| Domain | NOD | 9.79e-07 | 4 | 118 | 3 | PF06816 | |
| Domain | NOD | 9.79e-07 | 4 | 118 | 3 | SM01338 | |
| Domain | NODP | 9.79e-07 | 4 | 118 | 3 | SM01339 | |
| Domain | - | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 1.26e-06 | 679 | 118 | 17 | 3.30.160.60 |
| Domain | Ldl_recept_b | 1.44e-06 | 14 | 118 | 4 | PF00058 | |
| Domain | LDLRB | 1.44e-06 | 14 | 118 | 4 | PS51120 | |
| Domain | zf-C2H2 | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 1.67e-06 | 693 | 118 | 17 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 1.70e-06 | 694 | 118 | 17 | IPR013087 |
| Domain | LY | 1.96e-06 | 15 | 118 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.96e-06 | 15 | 118 | 4 | IPR000033 | |
| Domain | EGF_extracell | 2.12e-06 | 60 | 118 | 6 | IPR013111 | |
| Domain | EGF_2 | 2.12e-06 | 60 | 118 | 6 | PF07974 | |
| Domain | Galactose-bd-like | 2.18e-06 | 94 | 118 | 7 | IPR008979 | |
| Domain | Guanine_nucleotide-bd_bsu | 2.44e-06 | 5 | 118 | 3 | IPR016346 | |
| Domain | LNR | 2.44e-06 | 5 | 118 | 3 | PS50258 | |
| Domain | VWFC_1 | 2.98e-06 | 36 | 118 | 5 | PS01208 | |
| Domain | VWFC_2 | 3.93e-06 | 38 | 118 | 5 | PS50184 | |
| Domain | VWC | 3.93e-06 | 38 | 118 | 5 | SM00214 | |
| Domain | zf-C2H2_6 | ZBTB16 ZNF549 ZBTB41 ZNF354C ZNF551 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF433 | 4.93e-06 | 314 | 118 | 11 | PF13912 |
| Domain | LDLR_class-A_CS | 5.10e-06 | 40 | 118 | 5 | IPR023415 | |
| Domain | VWF_dom | 6.52e-06 | 42 | 118 | 5 | IPR001007 | |
| Domain | ZINC_FINGER_C2H2_2 | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 7.41e-06 | 775 | 118 | 17 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 7.66e-06 | 777 | 118 | 17 | PS00028 |
| Domain | Ldl_recept_a | 9.23e-06 | 45 | 118 | 5 | PF00057 | |
| Domain | - | 1.03e-05 | 46 | 118 | 5 | 4.10.400.10 | |
| Domain | Znf_C2H2-like | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 1.05e-05 | 796 | 118 | 17 | IPR015880 |
| Domain | Znf_C2H2 | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 1.21e-05 | 805 | 118 | 17 | IPR007087 |
| Domain | LDLRA_1 | 1.27e-05 | 48 | 118 | 5 | PS01209 | |
| Domain | ZnF_C2H2 | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 1.27e-05 | 808 | 118 | 17 | SM00355 |
| Domain | LDrepeatLR_classA_rpt | 1.41e-05 | 49 | 118 | 5 | IPR002172 | |
| Domain | LDLa | 1.41e-05 | 49 | 118 | 5 | SM00192 | |
| Domain | LDLRA_2 | 1.41e-05 | 49 | 118 | 5 | PS50068 | |
| Domain | Ephrin_rec_like | 1.73e-05 | 25 | 118 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.73e-05 | 25 | 118 | 4 | IPR011641 | |
| Domain | Gprotein_B | 2.86e-05 | 10 | 118 | 3 | IPR001632 | |
| Domain | GFP-like | 3.91e-05 | 11 | 118 | 3 | IPR023413 | |
| Domain | - | 3.91e-05 | 11 | 118 | 3 | 2.40.155.10 | |
| Domain | Peptidase_M43 | 3.96e-05 | 2 | 118 | 2 | IPR008754 | |
| Domain | Peptidase_M43 | 3.96e-05 | 2 | 118 | 2 | PF05572 | |
| Domain | C8 | 5.19e-05 | 12 | 118 | 3 | PF08742 | |
| Domain | TIL | 5.19e-05 | 12 | 118 | 3 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 6.71e-05 | 13 | 118 | 3 | IPR014853 | |
| Domain | C8 | 6.71e-05 | 13 | 118 | 3 | SM00832 | |
| Domain | TIL_dom | 8.51e-05 | 14 | 118 | 3 | IPR002919 | |
| Domain | LAM_G_DOMAIN | 9.47e-05 | 38 | 118 | 4 | PS50025 | |
| Domain | - | 9.86e-05 | 73 | 118 | 5 | 2.60.120.260 | |
| Domain | - | 1.05e-04 | 39 | 118 | 4 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 1.16e-04 | 40 | 118 | 4 | PF02210 | |
| Domain | DUF3454 | 1.18e-04 | 3 | 118 | 2 | PF11936 | |
| Domain | Myxo_disulph_rpt | 1.18e-04 | 3 | 118 | 2 | IPR011936 | |
| Domain | DUF3454_notch | 1.18e-04 | 3 | 118 | 2 | IPR024600 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | HSPG2 VWF MATN3 LAMA3 LAMA5 LAMC1 ITGA7 ITGAD FBLN1 FBN1 LRP4 NID1 LTBP2 LTBP3 LTBP4 FBN3 | 1.22e-10 | 300 | 94 | 16 | M610 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.90e-08 | 30 | 94 | 6 | M27216 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.47e-07 | 37 | 94 | 6 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.31e-07 | 44 | 94 | 6 | M26969 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.03e-07 | 76 | 94 | 7 | M27219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.27e-06 | 13 | 94 | 4 | M47423 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.39e-06 | 84 | 94 | 7 | M7098 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.84e-06 | 5 | 94 | 3 | M27411 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.93e-06 | 66 | 94 | 6 | M18 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | VWF LAMA3 LAMA5 LAMC1 ITGA7 ITGAD PPP2R3A EGF GNB4 GNB1 GNB2 | 5.17e-06 | 302 | 94 | 11 | M39719 |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 5.66e-06 | 6 | 94 | 3 | M27068 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.87e-06 | 68 | 94 | 6 | M27303 | |
| Pathway | WP_CANCER_PATHWAYS | LAMB4 ZBTB16 WNT2 LAMA3 LAMA5 LAMC1 JAG2 EGF GNB4 GNB1 GNB2 NOTCH1 NOTCH2 NOTCH4 | 6.29e-06 | 507 | 94 | 14 | M48302 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 8.30e-06 | 258 | 94 | 10 | MM14572 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.31e-05 | 46 | 94 | 5 | M239 | |
| Pathway | WP_PI3KAKT_SIGNALING | LAMB4 VWF LAMA3 LAMA5 LAMC1 ITGA7 PPP2R3A EGF GNB4 GNB1 GNB2 | 1.54e-05 | 339 | 94 | 11 | M39736 |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.57e-05 | 8 | 94 | 3 | M47850 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.89e-05 | 27 | 94 | 4 | M39545 | |
| Pathway | WP_FOCAL_ADHESION | 3.47e-05 | 187 | 94 | 8 | MM15913 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.09e-05 | 140 | 94 | 7 | M587 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 4.56e-05 | 11 | 94 | 3 | M47865 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.56e-05 | 11 | 94 | 3 | M158 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.68e-05 | 143 | 94 | 7 | M27275 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.40e-05 | 199 | 94 | 8 | M7253 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.78e-05 | 32 | 94 | 4 | MM14854 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 6.05e-05 | 12 | 94 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 6.05e-05 | 12 | 94 | 3 | M47533 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 6.17e-05 | 326 | 94 | 10 | MM15917 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 7.82e-05 | 13 | 94 | 3 | M47534 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.09e-04 | 71 | 94 | 5 | MM15590 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.15e-04 | 38 | 94 | 4 | MM14874 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.23e-04 | 15 | 94 | 3 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.28e-04 | 39 | 94 | 4 | MM14604 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.28e-04 | 39 | 94 | 4 | MM14601 | |
| Pathway | REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING | 1.41e-04 | 75 | 94 | 5 | M27874 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.51e-04 | 16 | 94 | 3 | M47424 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.55e-04 | 41 | 94 | 4 | M27778 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.16e-04 | 82 | 94 | 5 | MM15922 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.18e-04 | 18 | 94 | 3 | M614 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.24e-04 | 45 | 94 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 2.44e-04 | 46 | 94 | 4 | MM15971 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.55e-04 | 85 | 94 | 5 | M16441 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 2.57e-04 | 19 | 94 | 3 | MM15021 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 2.57e-04 | 19 | 94 | 3 | M926 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.60e-04 | 133 | 94 | 6 | MM15529 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.62e-04 | 250 | 94 | 8 | M27554 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.66e-04 | 47 | 94 | 4 | M646 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.66e-04 | 47 | 94 | 4 | M7946 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 2.84e-04 | 87 | 94 | 5 | M39465 | |
| Pathway | WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY | 2.88e-04 | 48 | 94 | 4 | M39427 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 3.01e-04 | 20 | 94 | 3 | MM15572 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 3.01e-04 | 20 | 94 | 3 | M27853 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.01e-04 | 20 | 94 | 3 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.12e-04 | 49 | 94 | 4 | M618 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 3.50e-04 | 21 | 94 | 3 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 3.50e-04 | 21 | 94 | 3 | MM15159 | |
| Pathway | WP_FOCAL_ADHESION | 3.65e-04 | 199 | 94 | 7 | M39402 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 4.03e-04 | 22 | 94 | 3 | MM15016 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 4.03e-04 | 22 | 94 | 3 | M841 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.34e-04 | 5 | 94 | 2 | MM14733 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 4.34e-04 | 5 | 94 | 2 | M22018 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 4.62e-04 | 23 | 94 | 3 | MM15033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 4.62e-04 | 23 | 94 | 3 | M47549 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 5.25e-04 | 24 | 94 | 3 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 5.25e-04 | 24 | 94 | 3 | MM15088 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 5.25e-04 | 24 | 94 | 3 | M11190 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 5.25e-04 | 24 | 94 | 3 | M18308 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 5.25e-04 | 24 | 94 | 3 | M47460 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 5.25e-04 | 24 | 94 | 3 | MM14794 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 5.69e-04 | 154 | 94 | 6 | M39739 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 5.94e-04 | 25 | 94 | 3 | MM15056 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 5.94e-04 | 25 | 94 | 3 | M39713 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 5.94e-04 | 25 | 94 | 3 | M811 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 5.94e-04 | 25 | 94 | 3 | M14301 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.37e-04 | 59 | 94 | 4 | M27218 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 6.37e-04 | 59 | 94 | 4 | M39886 | |
| Pathway | PID_NOTCH_PATHWAY | 6.37e-04 | 59 | 94 | 4 | M17 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 6.48e-04 | 6 | 94 | 2 | MM1543 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 6.68e-04 | 26 | 94 | 3 | MM15017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 6.68e-04 | 26 | 94 | 3 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 6.68e-04 | 26 | 94 | 3 | M47562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 6.68e-04 | 26 | 94 | 3 | M47557 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 6.68e-04 | 26 | 94 | 3 | M47456 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 7.24e-04 | 61 | 94 | 4 | M39540 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY | 7.48e-04 | 27 | 94 | 3 | M47454 | |
| Pathway | REACTOME_GPER1_SIGNALING | 7.48e-04 | 27 | 94 | 3 | MM15664 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 8.34e-04 | 28 | 94 | 3 | M6177 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 8.34e-04 | 28 | 94 | 3 | M10679 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 9.04e-04 | 7 | 94 | 2 | M27199 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 9.04e-04 | 7 | 94 | 2 | MM14734 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 9.25e-04 | 29 | 94 | 3 | M47466 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.02e-03 | 30 | 94 | 3 | M27772 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.02e-03 | 30 | 94 | 3 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 1.02e-03 | 30 | 94 | 3 | MM14542 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.13e-03 | 31 | 94 | 3 | MM15094 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.13e-03 | 31 | 94 | 3 | M47554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY | 1.13e-03 | 31 | 94 | 3 | M47455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY | 1.13e-03 | 31 | 94 | 3 | M47459 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 1.13e-03 | 31 | 94 | 3 | M47540 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 1.13e-03 | 31 | 94 | 3 | M47541 | |
| Pubmed | HSPG2 VWF LAMA3 LAMA5 LAMC1 FBLN1 FBN1 NID1 LTBP2 LTBP3 LTBP4 | 3.48e-12 | 146 | 119 | 11 | 27068509 | |
| Pubmed | HSPG2 FRAS1 VWF LAMA3 LAMA5 LAMC1 FBLN1 FBN1 NID1 LTBP2 LTBP4 | 1.51e-11 | 167 | 119 | 11 | 22159717 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | HSPG2 VWF CRLF1 LAMC1 SVEP1 FBLN1 FBN1 NID1 PAPPA LTBP2 FST LTBP4 | 6.40e-11 | 248 | 119 | 12 | 24006456 |
| Pubmed | 1.42e-10 | 153 | 119 | 10 | 25037231 | ||
| Pubmed | 3.09e-10 | 118 | 119 | 9 | 21078624 | ||
| Pubmed | 3.35e-10 | 12 | 119 | 5 | 16750824 | ||
| Pubmed | 5.33e-10 | 175 | 119 | 10 | 28071719 | ||
| Pubmed | 5.42e-10 | 13 | 119 | 5 | 12682087 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.26e-09 | 15 | 119 | 5 | 15895400 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.29e-09 | 101 | 119 | 8 | 20551380 | |
| Pubmed | 4.52e-09 | 7 | 119 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 4.52e-09 | 7 | 119 | 4 | 12846471 | |
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 9.02e-09 | 8 | 119 | 4 | 32948785 | |
| Pubmed | 9.02e-09 | 8 | 119 | 4 | 9858718 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.09e-08 | 79 | 119 | 7 | 18757743 | |
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 12122015 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 11118901 | ||
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 16245338 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.28e-08 | 135 | 119 | 8 | 28675934 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.69e-08 | 10 | 119 | 4 | 23665443 | |
| Pubmed | 2.69e-08 | 10 | 119 | 4 | 15623520 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 2.69e-08 | 10 | 119 | 4 | 16100707 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 FRAS1 CRLF1 NAGLU LAMA5 LAMC1 PLXND1 ITGA7 LRP1B JAG2 FBLN1 FBN1 LRP11 LRP4 NID1 LTBP2 LTBP3 NOTCH1 NOTCH2 | 2.73e-08 | 1201 | 119 | 19 | 35696571 |
| Pubmed | Differential expression of Notch genes in human osteoblastic cells. | 3.91e-08 | 3 | 119 | 3 | 11836628 | |
| Pubmed | Notch signaling: cell fate control and signal integration in development. | 3.91e-08 | 3 | 119 | 3 | 10221902 | |
| Pubmed | Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction. | 3.91e-08 | 3 | 119 | 3 | 18458347 | |
| Pubmed | The Notch-mediated circuitry in the evolution and generation of new cell lineages: the tooth model. | 3.91e-08 | 3 | 119 | 3 | 37330998 | |
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 4.22e-08 | 11 | 119 | 4 | 16607638 | |
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 4.22e-08 | 11 | 119 | 4 | 36792666 | |
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 12051813 | ||
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 10878608 | ||
| Pubmed | 4.22e-08 | 11 | 119 | 4 | 12866128 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.57e-08 | 97 | 119 | 7 | 27559042 | |
| Pubmed | 4.79e-08 | 29 | 119 | 5 | 22613833 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 4.79e-08 | 29 | 119 | 5 | 21402740 | |
| Pubmed | 5.65e-08 | 100 | 119 | 7 | 24859004 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 5.73e-08 | 30 | 119 | 5 | 24552588 | |
| Pubmed | 6.31e-08 | 12 | 119 | 4 | 15465494 | ||
| Pubmed | 6.82e-08 | 31 | 119 | 5 | 22274697 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | VWF NOTCH2NLA LAMA5 LAMC1 DGKD JAG2 FBLN1 FBN1 MEGF6 LTBP3 LTBP4 NOTCH1 NOTCH2 | 7.02e-08 | 560 | 119 | 13 | 21653829 |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 9.10e-08 | 13 | 119 | 4 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 9.10e-08 | 13 | 119 | 4 | 20558824 | |
| Pubmed | 1.27e-07 | 14 | 119 | 4 | 14757642 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 24145721 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 1.56e-07 | 4 | 119 | 3 | 19404845 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 28669409 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 18703315 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 15611103 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 11401408 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 1.56e-07 | 4 | 119 | 3 | 8898100 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 1543505 | ||
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 1.56e-07 | 4 | 119 | 3 | 32330268 | |
| Pubmed | The role of G protein beta subunits in the release of ATP from human erythrocytes. | 1.56e-07 | 4 | 119 | 3 | 12512701 | |
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.56e-07 | 4 | 119 | 3 | 11104663 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 1.56e-07 | 4 | 119 | 3 | 17920003 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 24398584 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 1.56e-07 | 4 | 119 | 3 | 28061457 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 11466531 | ||
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 24151014 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 1.56e-07 | 4 | 119 | 3 | 10194420 | |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 1.56e-07 | 4 | 119 | 3 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 1.56e-07 | 4 | 119 | 3 | 15917835 | |
| Pubmed | 1.73e-07 | 15 | 119 | 4 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.30e-07 | 16 | 119 | 4 | 12617809 | |
| Pubmed | 2.30e-07 | 16 | 119 | 4 | 17273555 | ||
| Pubmed | 2.30e-07 | 16 | 119 | 4 | 10842072 | ||
| Pubmed | 2.30e-07 | 16 | 119 | 4 | 16880404 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 FRAS1 NSD2 NAGLU TRMT1 LAMA5 RAPGEF1 PLXND1 JAG2 LLGL2 MEGF6 ZNF500 LRP4 LTBP3 LTBP4 NOTCH1 NOTCH2 | 2.35e-07 | 1105 | 119 | 17 | 35748872 |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | WNT2 PEX7 GSX2 NR6A1 KLF2 JAG2 LRP4 NOTCH1 FBXO15 NOTCH2 NOTCH4 | 2.52e-07 | 424 | 119 | 11 | 21731673 |
| Pubmed | 2.93e-07 | 41 | 119 | 5 | 22675208 | ||
| Pubmed | 3.00e-07 | 17 | 119 | 4 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 3.00e-07 | 17 | 119 | 4 | 15821257 | |
| Pubmed | 3.84e-07 | 18 | 119 | 4 | 18093989 | ||
| Pubmed | 3.84e-07 | 18 | 119 | 4 | 11311202 | ||
| Pubmed | 3.84e-07 | 18 | 119 | 4 | 15689374 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 11969289 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 7670489 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 11101851 | ||
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 3.89e-07 | 5 | 119 | 3 | 29856954 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 21124806 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 3.89e-07 | 5 | 119 | 3 | 15064243 | |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 23675950 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 12243745 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 11829758 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 15882997 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 27118257 | ||
| Pubmed | The notch pathway positively regulates programmed cell death during erythroid differentiation. | 4.21e-07 | 44 | 119 | 5 | 17476283 | |
| Pubmed | 4.85e-07 | 19 | 119 | 4 | 16518823 | ||
| Pubmed | 7.45e-07 | 21 | 119 | 4 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 7.45e-07 | 21 | 119 | 4 | 14702043 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 9111338 | ||
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 10958687 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 7.75e-07 | 6 | 119 | 3 | 12244553 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 16371464 | ||
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 18299578 | ||
| Pubmed | Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. | 7.75e-07 | 6 | 119 | 3 | 10544250 | |
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 7.75e-07 | 6 | 119 | 3 | 15019995 | |
| Interaction | IGFL3 interactions | FRAS1 LAMA3 LAMA5 ITGA7 LRP1B JAG2 FBLN1 LRP11 LRP4 NOTCH1 NOTCH2 | 5.09e-13 | 75 | 116 | 11 | int:IGFL3 |
| Interaction | NTN5 interactions | 6.42e-13 | 24 | 116 | 8 | int:NTN5 | |
| Interaction | FBXO2 interactions | HSPG2 FRAS1 CRLF1 NAGLU LAMA3 LAMA5 LAMC1 PLXND1 PTPRU LRP1B JAG2 FBN1 NID1 LTBP4 NOTCH1 NOTCH2 EPHA1 | 2.12e-10 | 411 | 116 | 17 | int:FBXO2 |
| Interaction | PRG2 interactions | HSPG2 FRAS1 CRLF1 NAGLU LAMA5 LAMC1 PTPRU ITGA7 JAG2 PAPPA LTBP3 LTBP4 NOTCH1 NOTCH2 | 1.04e-09 | 285 | 116 | 14 | int:PRG2 |
| Interaction | CACNA1A interactions | 2.34e-09 | 123 | 116 | 10 | int:CACNA1A | |
| Interaction | ZNF707 interactions | 1.75e-08 | 79 | 116 | 8 | int:ZNF707 | |
| Interaction | MFAP5 interactions | 1.88e-08 | 52 | 116 | 7 | int:MFAP5 | |
| Interaction | ZFP41 interactions | 3.63e-08 | 57 | 116 | 7 | int:ZFP41 | |
| Interaction | ZNF408 interactions | 1.60e-07 | 145 | 116 | 9 | int:ZNF408 | |
| Interaction | SIRPD interactions | 6.44e-07 | 86 | 116 | 7 | int:SIRPD | |
| Interaction | CFC1 interactions | 6.74e-07 | 126 | 116 | 8 | int:CFC1 | |
| Interaction | HOXA1 interactions | ZBTB16 VWF NOTCH2NLA LAMA5 JAG2 FBLN1 FBN1 MEGF6 LTBP3 FST LTBP4 NOTCH1 | 1.02e-06 | 356 | 116 | 12 | int:HOXA1 |
| Interaction | ZNF74 interactions | 1.41e-06 | 34 | 116 | 5 | int:ZNF74 | |
| Interaction | SLURP1 interactions | 1.85e-06 | 144 | 116 | 8 | int:SLURP1 | |
| Interaction | EDN3 interactions | 3.01e-06 | 108 | 116 | 7 | int:EDN3 | |
| Interaction | LGALS1 interactions | FRAS1 CRLF1 NAGLU LAMA5 PLXND1 DPP8 ITGA7 JAG2 GNB2 NOTCH1 NOTCH2 | 3.47e-06 | 332 | 116 | 11 | int:LGALS1 |
| Interaction | LY86 interactions | 4.64e-06 | 217 | 116 | 9 | int:LY86 | |
| Interaction | IL5RA interactions | 7.54e-06 | 124 | 116 | 7 | int:IL5RA | |
| Interaction | CBLN4 interactions | 8.82e-06 | 127 | 116 | 7 | int:CBLN4 | |
| Interaction | WNT3A interactions | 9.02e-06 | 49 | 116 | 5 | int:WNT3A | |
| Interaction | GFI1B interactions | 1.38e-05 | 136 | 116 | 7 | int:GFI1B | |
| Interaction | BRICD5 interactions | 1.67e-05 | 194 | 116 | 8 | int:BRICD5 | |
| Interaction | ELN interactions | 2.21e-05 | 29 | 116 | 4 | int:ELN | |
| Interaction | ZNF517 interactions | 2.21e-05 | 29 | 116 | 4 | int:ZNF517 | |
| Interaction | ZNF444 interactions | 3.41e-05 | 106 | 116 | 6 | int:ZNF444 | |
| Interaction | FBN2 interactions | 3.63e-05 | 65 | 116 | 5 | int:FBN2 | |
| Interaction | FBLN2 interactions | 3.91e-05 | 66 | 116 | 5 | int:FBLN2 | |
| Interaction | ZNF563 interactions | 3.94e-05 | 12 | 116 | 3 | int:ZNF563 | |
| Interaction | GNGT2 interactions | 3.94e-05 | 12 | 116 | 3 | int:GNGT2 | |
| Interaction | ZNF611 interactions | 3.94e-05 | 12 | 116 | 3 | int:ZNF611 | |
| Interaction | CDHR4 interactions | 4.52e-05 | 68 | 116 | 5 | int:CDHR4 | |
| Interaction | IGSF5 interactions | 6.46e-05 | 14 | 116 | 3 | int:IGSF5 | |
| Interaction | FBXO6 interactions | HSPG2 FRAS1 POLR2B NAGLU LAMA3 LAMA5 LAMC1 PTPRU FLG2 LRPPRC FBLN1 GNB4 LTBP3 LTBP4 | 6.49e-05 | 717 | 116 | 14 | int:FBXO6 |
| Interaction | PTPRK interactions | 7.47e-05 | 177 | 116 | 7 | int:PTPRK | |
| Interaction | MBD1 interactions | 8.23e-05 | 77 | 116 | 5 | int:MBD1 | |
| Interaction | CST9L interactions | 8.75e-05 | 78 | 116 | 5 | int:CST9L | |
| Interaction | NELL1 interactions | 9.85e-05 | 42 | 116 | 4 | int:NELL1 | |
| Interaction | SDF2L1 interactions | 1.04e-04 | 322 | 116 | 9 | int:SDF2L1 | |
| Interaction | PI15 interactions | 1.18e-04 | 83 | 116 | 5 | int:PI15 | |
| Interaction | GNG11 interactions | 1.19e-04 | 17 | 116 | 3 | int:GNG11 | |
| Interaction | MAML2 interactions | 1.19e-04 | 17 | 116 | 3 | int:MAML2 | |
| Interaction | NMU interactions | 1.32e-04 | 85 | 116 | 5 | int:NMU | |
| Interaction | RGS6 interactions | 1.42e-04 | 18 | 116 | 3 | int:RGS6 | |
| Interaction | SORL1 interactions | 1.48e-04 | 138 | 116 | 6 | int:SORL1 | |
| Interaction | ATF7IP interactions | 1.48e-04 | 138 | 116 | 6 | int:ATF7IP | |
| Interaction | MYOC interactions | 1.67e-04 | 48 | 116 | 4 | int:MYOC | |
| Interaction | NID1 interactions | 1.67e-04 | 48 | 116 | 4 | int:NID1 | |
| Interaction | CCN6 interactions | 1.68e-04 | 19 | 116 | 3 | int:CCN6 | |
| Interaction | HBEGF interactions | 1.68e-04 | 19 | 116 | 3 | int:HBEGF | |
| Interaction | PRG3 interactions | 1.81e-04 | 49 | 116 | 4 | int:PRG3 | |
| Interaction | FOXD4L6 interactions | 1.81e-04 | 49 | 116 | 4 | int:FOXD4L6 | |
| Interaction | SUSD4 interactions | 1.96e-04 | 50 | 116 | 4 | int:SUSD4 | |
| Interaction | GNG7 interactions | 1.97e-04 | 20 | 116 | 3 | int:GNG7 | |
| Interaction | MAML3 interactions | 1.97e-04 | 20 | 116 | 3 | int:MAML3 | |
| Interaction | RLN1 interactions | 2.01e-04 | 93 | 116 | 5 | int:RLN1 | |
| Interaction | C9orf163 interactions | 2.11e-04 | 51 | 116 | 4 | int:C9orf163 | |
| Interaction | TOP3B interactions | HSPG2 FRAS1 NSD2 NAGLU TRMT1 LAMA5 RAPGEF1 PLXND1 JAG2 CNBP ZNF250 LLGL2 MEGF6 ZNF500 LRP4 HELZ LTBP3 LTBP4 NOTCH1 NOTCH2 | 2.61e-04 | 1470 | 116 | 20 | int:TOP3B |
| Interaction | WNT2 interactions | 3.03e-04 | 23 | 116 | 3 | int:WNT2 | |
| Interaction | ZNF282 interactions | 3.03e-04 | 23 | 116 | 3 | int:ZNF282 | |
| Interaction | GNG3 interactions | 3.44e-04 | 24 | 116 | 3 | int:GNG3 | |
| Interaction | LYPD1 interactions | 3.48e-04 | 58 | 116 | 4 | int:LYPD1 | |
| Interaction | GNG4 interactions | 3.90e-04 | 25 | 116 | 3 | int:GNG4 | |
| Interaction | ATXN7 interactions | 4.20e-04 | 109 | 116 | 5 | int:ATXN7 | |
| Interaction | GNGT1 interactions | 4.39e-04 | 26 | 116 | 3 | int:GNGT1 | |
| Interaction | P2RX7 interactions | 4.39e-04 | 26 | 116 | 3 | int:P2RX7 | |
| Interaction | DLL4 interactions | 4.85e-04 | 6 | 116 | 2 | int:DLL4 | |
| Interaction | CXCL5 interactions | 4.91e-04 | 27 | 116 | 3 | int:CXCL5 | |
| Interaction | NOTCH3 interactions | 4.96e-04 | 113 | 116 | 5 | int:NOTCH3 | |
| Interaction | OIT3 interactions | 5.38e-04 | 65 | 116 | 4 | int:OIT3 | |
| Interaction | IGHD interactions | 5.48e-04 | 28 | 116 | 3 | int:IGHD | |
| Interaction | LAMA1 interactions | 5.70e-04 | 66 | 116 | 4 | int:LAMA1 | |
| Interaction | LAMA5 interactions | 5.81e-04 | 117 | 116 | 5 | int:LAMA5 | |
| Interaction | LTBP4 interactions | 6.04e-04 | 67 | 116 | 4 | int:LTBP4 | |
| Interaction | CEACAM8 interactions | 6.28e-04 | 119 | 116 | 5 | int:CEACAM8 | |
| Interaction | NCR3 interactions | 6.52e-04 | 120 | 116 | 5 | int:NCR3 | |
| Interaction | COL4A3 interactions | 6.74e-04 | 30 | 116 | 3 | int:COL4A3 | |
| Interaction | LAMC2 interactions | 6.74e-04 | 30 | 116 | 3 | int:LAMC2 | |
| Interaction | ZNF594 interactions | 6.77e-04 | 7 | 116 | 2 | int:ZNF594 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZBTB16 ZNF577 ZNF175 ZNF549 ZBTB41 ZNF354C ZNF551 KLF2 ZNF250 ZNF10 ZNF836 ZNF283 ZNF500 ZNF81 ZNF433 ZNF222 ZNF304 | 7.80e-08 | 718 | 90 | 17 | 28 |
| GeneFamily | Laminin subunits | 2.76e-07 | 12 | 90 | 4 | 626 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 4.75e-07 | 4 | 90 | 3 | 628 | |
| GeneFamily | Pappalysins|Sushi domain containing | 2.45e-05 | 2 | 90 | 2 | 897 | |
| GeneFamily | Low density lipoprotein receptors | 3.29e-05 | 13 | 90 | 3 | 634 | |
| GeneFamily | WD repeat domain containing | 3.32e-04 | 262 | 90 | 7 | 362 | |
| GeneFamily | Fibronectin type III domain containing | 1.22e-03 | 160 | 90 | 5 | 555 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.14e-03 | 14 | 90 | 2 | 1095 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.87e-03 | 57 | 90 | 3 | 1179 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.56e-03 | 18 | 90 | 2 | 1160 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 6.82e-03 | 25 | 90 | 2 | 74 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.56e-03 | 161 | 90 | 4 | 593 | |
| GeneFamily | Sterile alpha motif domain containing | 9.65e-03 | 88 | 90 | 3 | 760 | |
| Coexpression | NABA_MATRISOME | PAPPA2 HSPG2 LAMB4 FRAS1 VWF CRLF1 WNT2 MATN3 LAMA3 NTNG1 LAMA5 LAMC1 PLXND1 EPGN FLG2 ADAMTSL3 F7 SVEP1 MEP1A FBLN1 FBN1 PRG3 EGF MEGF6 ADAMTS20 NID1 PAPPA LTBP2 LTBP3 FST LTBP4 MUC5AC FBN3 | 1.73e-19 | 1026 | 118 | 33 | M5889 |
| Coexpression | NABA_MATRISOME | PAPPA2 HSPG2 FRAS1 VWF CRLF1 WNT2 MATN3 LAMA3 NTNG1 LAMA5 LAMC1 PLXND1 EPGN FLG2 ADAMTSL3 F7 SVEP1 MEP1A FBLN1 FBN1 PRG3 EGF MEGF6 ADAMTS20 NID1 PAPPA LTBP2 LTBP3 FST LTBP4 MUC5AC | 9.56e-18 | 1008 | 118 | 31 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 LAMB4 FRAS1 VWF MATN3 LAMA3 NTNG1 LAMA5 LAMC1 SVEP1 FBLN1 FBN1 PRG3 NID1 LTBP2 LTBP3 LTBP4 FBN3 | 4.16e-16 | 275 | 118 | 18 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 FRAS1 VWF MATN3 LAMA3 NTNG1 LAMA5 LAMC1 SVEP1 FBLN1 FBN1 NID1 LTBP2 LTBP3 LTBP4 FBN3 | 6.15e-16 | 196 | 118 | 16 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FRAS1 VWF MATN3 LAMA3 NTNG1 LAMA5 LAMC1 SVEP1 FBLN1 FBN1 PRG3 NID1 LTBP2 LTBP3 LTBP4 | 9.38e-14 | 270 | 118 | 16 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 VWF MATN3 LAMA3 NTNG1 LAMA5 LAMC1 SVEP1 FBLN1 FBN1 NID1 LTBP2 LTBP3 LTBP4 | 1.98e-13 | 191 | 118 | 14 | MM17059 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 5.16e-10 | 40 | 118 | 7 | M5887 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 2.49e-08 | 20 | 118 | 5 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 5.35e-08 | 23 | 118 | 5 | M48001 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.81e-07 | 16 | 118 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.81e-07 | 16 | 118 | 4 | M2207 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PAPPA2 CRLF1 WNT2 PLXND1 EPGN FLG2 ADAMTSL3 F7 MEP1A EGF MEGF6 ADAMTS20 PAPPA FST MUC5AC | 1.18e-06 | 738 | 118 | 15 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PAPPA2 CRLF1 WNT2 PLXND1 EPGN FLG2 ADAMTSL3 F7 MEP1A EGF MEGF6 ADAMTS20 PAPPA FST MUC5AC | 1.47e-06 | 751 | 118 | 15 | M5885 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | VWF LAMA5 LAMC1 PLXND1 ITGA7 FBLN1 FBN1 NID1 PAPPA LTBP2 FST NOTCH4 | 3.09e-06 | 505 | 118 | 12 | M39167 |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.53e-05 | 117 | 118 | 6 | M39300 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.47e-05 | 261 | 118 | 8 | M1834 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN | 3.50e-05 | 200 | 118 | 7 | M9657 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.50e-05 | 200 | 118 | 7 | M5930 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.34e-05 | 479 | 118 | 10 | M2573 | |
| Coexpression | DURAND_STROMA_S_UP | 6.61e-05 | 300 | 118 | 8 | M2581 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 6.80e-05 | 483 | 118 | 10 | MM1082 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 6.91e-05 | 18 | 118 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 6.91e-05 | 18 | 118 | 3 | M13796 | |
| Coexpression | DURAND_STROMA_S_UP | 7.24e-05 | 304 | 118 | 8 | MM1083 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 8.18e-05 | 19 | 118 | 3 | M16026 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 9.79e-05 | 163 | 118 | 6 | M12112 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 1.12e-04 | 167 | 118 | 6 | M2395 | |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 1.37e-04 | 58 | 118 | 4 | M2402 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS | 1.44e-04 | 175 | 118 | 6 | MM3643 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 1.74e-04 | 440 | 118 | 9 | M39039 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 1.95e-04 | 185 | 118 | 6 | MM1072 | |
| Coexpression | ALONSO_METASTASIS_EMT_DN | 1.99e-04 | 5 | 118 | 2 | M3029 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 2.50e-04 | 124 | 118 | 5 | M45686 | |
| Coexpression | GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP | 2.74e-04 | 197 | 118 | 6 | M8426 | |
| Coexpression | GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN | 2.97e-04 | 200 | 118 | 6 | M6580 | |
| Coexpression | GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN | 2.97e-04 | 200 | 118 | 6 | M3755 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN | 2.97e-04 | 200 | 118 | 6 | M4354 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL | 3.17e-04 | 72 | 118 | 4 | M45791 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | ERBB3 ZBTB16 TBC1D30 MATN3 DGKD ITGA7 F7 SVEP1 DZANK1 FBLN1 SPAG16 | 3.24e-04 | 699 | 118 | 11 | M4960 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | HSPG2 VWF LAMA3 LAMA5 LAMC1 PLXND1 SHROOM4 NID1 GNB4 LTBP2 LTBP4 NOTCH4 | 4.37e-06 | 456 | 110 | 12 | GSM777032_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | HSPG2 VWF LAMA3 LAMA5 LAMC1 PLXND1 SHROOM4 NID1 GNB4 LTBP2 LTBP4 NOTCH4 | 4.68e-06 | 459 | 110 | 12 | GSM777037_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.14e-05 | 97 | 110 | 6 | GSM777043_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.39e-05 | 336 | 110 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | placenta | 8.54e-05 | 349 | 110 | 9 | placenta | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | ZBTB16 CRLF1 LAMC1 ADAMTSL3 SVEP1 FBLN1 FBN1 NID1 PAPPA LTBP2 LTBP4 | 5.06e-12 | 194 | 119 | 11 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | FRAS1 ZBTB16 NTNG1 LAMC1 ADAMTSL3 SVEP1 FBLN1 FBN1 NID1 LTBP2 | 1.07e-10 | 191 | 119 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | FRAS1 ZBTB16 NTNG1 LAMC1 ADAMTSL3 SVEP1 FBLN1 FBN1 NID1 LTBP2 | 1.13e-10 | 192 | 119 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.99e-09 | 187 | 119 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-09 | 190 | 119 | 9 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.40e-09 | 191 | 119 | 9 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-09 | 192 | 119 | 9 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-09 | 193 | 119 | 9 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-09 | 193 | 119 | 9 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.63e-09 | 193 | 119 | 9 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-09 | 193 | 119 | 9 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-09 | 193 | 119 | 9 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.75e-09 | 194 | 119 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.88e-09 | 195 | 119 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.88e-09 | 195 | 119 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.01e-09 | 196 | 119 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.14e-09 | 197 | 119 | 9 | a312d9cf4ced949307eb9620be4eed926300b892 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.14e-09 | 197 | 119 | 9 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.14e-09 | 197 | 119 | 9 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.14e-09 | 197 | 119 | 9 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.29e-09 | 198 | 119 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.29e-09 | 198 | 119 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.29e-09 | 198 | 119 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.44e-09 | 199 | 119 | 9 | b15304d3d3f6c254969b54a61bee3d9f368840b2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.44e-09 | 199 | 119 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-09 | 200 | 119 | 9 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.59e-09 | 200 | 119 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-09 | 200 | 119 | 9 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-09 | 200 | 119 | 9 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-09 | 200 | 119 | 9 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.76e-08 | 168 | 119 | 8 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-08 | 177 | 119 | 8 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.89e-08 | 179 | 119 | 8 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.89e-08 | 179 | 119 | 8 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.15e-08 | 181 | 119 | 8 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.29e-08 | 182 | 119 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.29e-08 | 182 | 119 | 8 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.73e-08 | 185 | 119 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.89e-08 | 186 | 119 | 8 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.05e-08 | 187 | 119 | 8 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-08 | 187 | 119 | 8 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-08 | 187 | 119 | 8 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-08 | 187 | 119 | 8 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.23e-08 | 188 | 119 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-08 | 189 | 119 | 8 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-08 | 189 | 119 | 8 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-08 | 189 | 119 | 8 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-08 | 189 | 119 | 8 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.40e-08 | 189 | 119 | 8 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.59e-08 | 190 | 119 | 8 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.59e-08 | 190 | 119 | 8 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-08 | 191 | 119 | 8 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-08 | 192 | 119 | 8 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-08 | 192 | 119 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 4.97e-08 | 192 | 119 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-08 | 192 | 119 | 8 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-08 | 192 | 119 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-08 | 192 | 119 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.97e-08 | 192 | 119 | 8 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-08 | 193 | 119 | 8 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.18e-08 | 193 | 119 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.18e-08 | 193 | 119 | 8 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 5.39e-08 | 194 | 119 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 5.39e-08 | 194 | 119 | 8 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-08 | 194 | 119 | 8 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-08 | 195 | 119 | 8 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-08 | 195 | 119 | 8 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-08 | 195 | 119 | 8 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 5.61e-08 | 195 | 119 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-08 | 195 | 119 | 8 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.61e-08 | 195 | 119 | 8 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.61e-08 | 195 | 119 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-08 | 195 | 119 | 8 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-08 | 195 | 119 | 8 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-08 | 195 | 119 | 8 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.83e-08 | 196 | 119 | 8 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-08 | 196 | 119 | 8 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.83e-08 | 196 | 119 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.83e-08 | 196 | 119 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-08 | 196 | 119 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-08 | 196 | 119 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.06e-08 | 197 | 119 | 8 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-08 | 197 | 119 | 8 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.31e-08 | 198 | 119 | 8 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.31e-08 | 198 | 119 | 8 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-08 | 198 | 119 | 8 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.31e-08 | 198 | 119 | 8 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 6.31e-08 | 198 | 119 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.31e-08 | 198 | 119 | 8 | d1f54ed3ef5e05ebda7da999e172d168dc6802cd | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.31e-08 | 198 | 119 | 8 | 8d6b0b9da7c1e64155cbcbb04ad38d129a29030c | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.31e-08 | 198 | 119 | 8 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.31e-08 | 198 | 119 | 8 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.56e-08 | 199 | 119 | 8 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.56e-08 | 199 | 119 | 8 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 6.56e-08 | 199 | 119 | 8 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 6.56e-08 | 199 | 119 | 8 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.56e-08 | 199 | 119 | 8 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.56e-08 | 199 | 119 | 8 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 6.56e-08 | 199 | 119 | 8 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.56e-08 | 199 | 119 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| Drug | Rgd Peptide | LAMB4 VWF LAMA3 LAMA5 LAMC1 DPP8 ITGA7 ITGAD FBLN1 FBN1 EGF NID1 FBN3 | 3.56e-10 | 239 | 118 | 13 | CID000104802 |
| Drug | kalinin | 1.39e-08 | 55 | 118 | 7 | CID000032518 | |
| Drug | AC1L1G72 | 2.20e-07 | 11 | 118 | 4 | CID000003553 | |
| Drug | LMWH | PAPPA2 HSPG2 LAMB4 ERBB3 VWF POLR2B LAMA3 LAMA5 LAMC1 F7 FBLN1 PRG3 EGF PAPPA FST | 1.77e-06 | 663 | 118 | 15 | CID000000772 |
| Drug | trypanothione disulfide | 8.54e-06 | 140 | 118 | 7 | CID000115098 | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; PC3; HT_HG-U133A | 9.87e-06 | 200 | 118 | 8 | 6407_DN | |
| Drug | CC270 | 1.37e-05 | 59 | 118 | 5 | CID006918852 | |
| Drug | AC1L9INI | 1.37e-05 | 59 | 118 | 5 | CID000445839 | |
| Drug | AC1L1B58 | 1.47e-05 | 29 | 118 | 4 | CID000001288 | |
| Drug | LG 5 | 1.49e-05 | 60 | 118 | 5 | CID011840957 | |
| Drug | I-Q-S | 1.73e-05 | 156 | 118 | 7 | CID000003540 | |
| Drug | pyrachlostrobin | HSPG2 MATN3 LAMA5 LAMC1 ADAMTSL3 SVEP1 FBN1 CNTNAP4 LRP4 NID1 PAPPA LTBP2 LTBP3 NOTCH1 NOTCH2 | 1.98e-05 | 811 | 118 | 15 | ctd:C513428 |
| Drug | BM165 | 2.17e-05 | 11 | 118 | 3 | CID003352881 | |
| Drug | AC1L1C2F | 2.35e-05 | 110 | 118 | 6 | CID000001711 | |
| Drug | Raloxifene Hydrochloride | ERBB3 VWF POLR2B LAMC1 PLXND1 ADAMTSL3 CNBP DEFB1 TMPRSS3 PAPPA GNB4 GNB1 FST EPHA1 ZNF222 | 3.73e-05 | 857 | 118 | 15 | ctd:D020849 |
| Drug | Calcort | 4.42e-05 | 38 | 118 | 4 | CID000026709 | |
| Drug | Ikvav | 4.42e-05 | 38 | 118 | 4 | CID000131343 | |
| Drug | A0395 | 4.44e-05 | 75 | 118 | 5 | CID009906466 | |
| Drug | 2-amino-5-methylpyridine | 5.04e-05 | 77 | 118 | 5 | CID000015348 | |
| Drug | YIGSR | 5.70e-05 | 79 | 118 | 5 | CID000123977 | |
| Drug | chondroitin sulfate | 5.91e-05 | 413 | 118 | 10 | CID000024766 | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 6.51e-05 | 192 | 118 | 7 | 3391_UP | |
| Drug | Etifenin [63245-28-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 6.95e-05 | 194 | 118 | 7 | 4117_UP | |
| Drug | hyaluronan | 6.97e-05 | 263 | 118 | 8 | CID000024759 | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 7.18e-05 | 195 | 118 | 7 | 6176_UP | |
| Drug | Grgds | 7.22e-05 | 83 | 118 | 5 | CID000123811 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 7.22e-05 | 83 | 118 | 5 | CID011968896 | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 2243_UP | |
| Drug | Sulfanilamide [63-74-1]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 7.41e-05 | 196 | 118 | 7 | 6810_UP | |
| Drug | lead stearate | 7.65e-05 | 84 | 118 | 5 | CID000061258 | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 3867_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 3639_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 2328_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 7.65e-05 | 197 | 118 | 7 | 4797_UP | |
| Drug | 4',5'-dimethylfluorescein | 7.96e-05 | 3 | 118 | 2 | CID003082937 | |
| Drug | NSC 714187 | 8.09e-05 | 85 | 118 | 5 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 8.56e-05 | 86 | 118 | 5 | CID000001322 | |
| Drug | funiferine N-oxide | 1.21e-04 | 49 | 118 | 4 | CID000191631 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 3.18e-06 | 8 | 115 | 3 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Marfan Syndrome | 9.30e-06 | 11 | 115 | 3 | C0024796 | |
| Disease | Glioblastoma | 1.48e-05 | 79 | 115 | 5 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.99e-05 | 84 | 115 | 5 | C0334588 | |
| Disease | FEV/FEC ratio | HSPG2 FRAS1 ERBB3 GSX2 DGKD ADAMTSL3 ZNF354C TG FBLN1 FBN1 LLGL2 MEGF6 LTBP2 LTBP3 FST LTBP4 | 2.28e-05 | 1228 | 115 | 16 | EFO_0004713 |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.54e-05 | 15 | 115 | 3 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.54e-05 | 15 | 115 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 2.54e-05 | 15 | 115 | 3 | C0154091 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.05e-05 | 49 | 115 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 4.51e-05 | 3 | 115 | 2 | C0265313 | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.51e-05 | 3 | 115 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 4.51e-05 | 3 | 115 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 4.51e-05 | 3 | 115 | 2 | C1869114 | |
| Disease | Carcinoma of bladder | 4.51e-05 | 18 | 115 | 3 | C0699885 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 5.13e-05 | 52 | 115 | 4 | C0023452 | |
| Disease | lymphocyte count | FRAS1 ERBB3 ZBTB16 ZAN PEPD GSX2 DGKD PLXND1 KLF2 NFE2L3 FBN1 EGF HELZ PAPPA LTBP2 LTBP3 NOTCH2 | 5.28e-05 | 1464 | 115 | 17 | EFO_0004587 |
| Disease | carotid artery disease (is_marker_for) | 5.34e-05 | 19 | 115 | 3 | DOID:3407 (is_marker_for) | |
| Disease | coagulation factor measurement | 6.26e-05 | 20 | 115 | 3 | EFO_0004634 | |
| Disease | cortical surface area measurement | ERBB3 ZBTB16 ZAN NBEAL1 LAMC1 PLXND1 ADAMTSL3 ZNF354C SVEP1 TG JAG2 FBN1 MEGF6 ADAMTS20 PAPPA FBN3 | 6.75e-05 | 1345 | 115 | 16 | EFO_0010736 |
| Disease | Glioblastoma Multiforme | 7.60e-05 | 111 | 115 | 5 | C1621958 | |
| Disease | Malignant neoplasm of skin | 8.45e-05 | 59 | 115 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 8.45e-05 | 59 | 115 | 4 | C0037286 | |
| Disease | Weill-Marchesani syndrome | 8.99e-05 | 4 | 115 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 8.99e-05 | 4 | 115 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | laminin measurement | 8.99e-05 | 4 | 115 | 2 | EFO_0020528 | |
| Disease | Skin Ulcer | 8.99e-05 | 4 | 115 | 2 | C0037299 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 9.63e-05 | 61 | 115 | 4 | C1961102 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.10e-04 | 24 | 115 | 3 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 1.40e-04 | 26 | 115 | 3 | DOID:1319 (implicated_via_orthology) | |
| Disease | Geleophysic dysplasia | 1.49e-04 | 5 | 115 | 2 | C3489726 | |
| Disease | Acromicric Dysplasia | 1.49e-04 | 5 | 115 | 2 | C0265287 | |
| Disease | arteriosclerosis (is_marker_for) | 1.96e-04 | 29 | 115 | 3 | DOID:2349 (is_marker_for) | |
| Disease | eosinophil count | ERBB3 ZNF577 CRLF2 LECT2 SVEP1 KLF2 TG CNBP PRG3 LTBP2 LTBP3 LTBP4 MUC5AC NOTCH1 NOTCH2 NOTCH4 | 2.16e-04 | 1488 | 115 | 16 | EFO_0004842 |
| Disease | Mammary Carcinoma, Human | 2.21e-04 | 525 | 115 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.21e-04 | 525 | 115 | 9 | C1257931 | |
| Disease | trefoil factor 1 measurement | 2.24e-04 | 6 | 115 | 2 | EFO_0021865 | |
| Disease | Mammary Neoplasms | 2.28e-04 | 527 | 115 | 9 | C1458155 | |
| Disease | Disproportionate short stature | 2.38e-04 | 77 | 115 | 4 | C0878659 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.63e-04 | 32 | 115 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 2.65e-04 | 538 | 115 | 9 | C0678222 | |
| Disease | waist-hip ratio | PAPPA2 WNT2 NAGLU PEPD PLXND1 ITGA7 ADAMTSL3 ZNF354C MEP1A PPP2R3A ADAMTS20 NID1 LTBP2 LTBP3 | 3.02e-04 | 1226 | 115 | 14 | EFO_0004343 |
| Disease | adenocarcinoma (implicated_via_orthology) | 3.12e-04 | 7 | 115 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | cholesteryl ester 16:2 measurement | 3.12e-04 | 7 | 115 | 2 | EFO_0021435 | |
| Disease | Polysyndactyly | 3.12e-04 | 7 | 115 | 2 | C0265553 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 3.12e-04 | 7 | 115 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | cervical cancer | 3.16e-04 | 34 | 115 | 3 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 3.45e-04 | 35 | 115 | 3 | C0007873 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.75e-04 | 447 | 115 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | cortical thickness | HSPG2 ERBB3 ZBTB16 NBEAL1 LAMC1 PLXND1 ADAMTSL3 TG JAG2 FBN1 LRP11 LRP4 ADAMTS20 | 4.06e-04 | 1113 | 115 | 13 | EFO_0004840 |
| Disease | Syndactyly | 4.15e-04 | 8 | 115 | 2 | C0039075 | |
| Disease | Colorectal Carcinoma | 4.32e-04 | 702 | 115 | 10 | C0009402 | |
| Disease | hemangiopericytoma (is_marker_for) | 5.32e-04 | 9 | 115 | 2 | DOID:264 (is_marker_for) | |
| Disease | Marfan Syndrome, Type I | 5.32e-04 | 9 | 115 | 2 | C4721845 | |
| Disease | Marfan syndrome (implicated_via_orthology) | 6.64e-04 | 10 | 115 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | open-angle glaucoma | 9.31e-04 | 191 | 115 | 5 | EFO_0004190 | |
| Disease | Mitral valve prolapse, response to surgery | 9.69e-04 | 12 | 115 | 2 | EFO_0009951, HP_0001634 | |
| Disease | stenosing tenosynovitis | 9.69e-04 | 12 | 115 | 2 | EFO_0010822 | |
| Disease | body composition measurement | 9.75e-04 | 193 | 115 | 5 | EFO_0005106 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 9.89e-04 | 50 | 115 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | L2 Acute Lymphoblastic Leukemia | 9.89e-04 | 50 | 115 | 3 | C0023453 | |
| Disease | hyperglycemia (is_marker_for) | 1.14e-03 | 13 | 115 | 2 | DOID:4195 (is_marker_for) | |
| Disease | gallbladder cancer (is_implicated_in) | 1.14e-03 | 13 | 115 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | IGFBP-3 measurement | 1.24e-03 | 54 | 115 | 3 | EFO_0004626 | |
| Disease | optic disc size measurement | 1.27e-03 | 205 | 115 | 5 | EFO_0004832 | |
| Disease | cup-to-disc ratio measurement | 1.51e-03 | 430 | 115 | 7 | EFO_0006939 | |
| Disease | obesity (implicated_via_orthology) | 1.57e-03 | 215 | 115 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.76e-03 | 61 | 115 | 3 | DOID:3587 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.18e-03 | 139 | 115 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | osteochondrodysplasia (is_implicated_in) | 2.47e-03 | 19 | 115 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | abnormal paneth cell measurement | 2.47e-03 | 19 | 115 | 2 | EFO_0007963 | |
| Disease | anorexia nervosa | 2.61e-03 | 70 | 115 | 3 | MONDO_0005351 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 2.61e-03 | 352 | 115 | 6 | EFO_0007014 | |
| Disease | neutrophil percentage of leukocytes | 2.72e-03 | 610 | 115 | 8 | EFO_0007990 | |
| Disease | Multiple Epiphyseal Dysplasia | 2.73e-03 | 20 | 115 | 2 | C0026760 | |
| Disease | perceived unattractiveness to mosquitos measurement | 2.83e-03 | 72 | 115 | 3 | EFO_0008380 | |
| Disease | Prostatic Neoplasms | 2.89e-03 | 616 | 115 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.89e-03 | 616 | 115 | 8 | C0376358 | |
| Disease | Colonic Neoplasms | 3.01e-03 | 152 | 115 | 4 | C0009375 | |
| Disease | Headache, HbA1c measurement | 3.01e-03 | 21 | 115 | 2 | EFO_0004541, HP_0002315 | |
| Disease | neuroimaging measurement | ERBB3 ZBTB16 NBEAL1 NAGLU LAMC1 PLXND1 TG JAG2 LRP11 ADAMTS20 PAPPA | 3.09e-03 | 1069 | 115 | 11 | EFO_0004346 |
| Disease | Malignant neoplasm of breast | ERBB3 VWF NSD2 JAG2 LLGL2 EGF FST ZNHIT2 NOTCH1 NOTCH2 NOTCH4 | 3.20e-03 | 1074 | 115 | 11 | C0006142 |
| Disease | vital capacity | PAPPA2 HSPG2 ZBTB16 POLR2B ADAMTSL3 SVEP1 LLGL2 LTBP2 LTBP3 GNB1 LTBP4 FBN3 | 3.23e-03 | 1236 | 115 | 12 | EFO_0004312 |
| Disease | Craniofacial Abnormalities | 3.30e-03 | 156 | 115 | 4 | C0376634 | |
| Disease | Paroxysmal atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C2585653 | |
| Disease | Splenomegaly | 3.31e-03 | 22 | 115 | 2 | C0038002 | |
| Disease | Unipolar Depression | 3.51e-03 | 259 | 115 | 5 | C0041696 | |
| Disease | Malignant tumor of colon | 3.53e-03 | 159 | 115 | 4 | C0007102 | |
| Disease | Atrial Fibrillation | 3.61e-03 | 160 | 115 | 4 | C0004238 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 3.61e-03 | 23 | 115 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | age of onset of asthma | 3.68e-03 | 79 | 115 | 3 | OBA_2001001 | |
| Disease | intraocular pressure measurement | 3.86e-03 | 509 | 115 | 7 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RFHTGEQLYTCLECG | 376 | Q86Y25 | |
| RNYSRGGVCVTHCNF | 521 | P21860 | |
| CFTGYTGERCEHLTL | 86 | Q6UW88 | |
| EGATICTCESGHYRA | 306 | P21709 | |
| RYCVLGCENFTSGRH | 381 | O00478 | |
| VTHVSGDNCCYTGSL | 136 | Q86XM0 | |
| HSGTYQCCARSQKSG | 106 | O95971 | |
| RGATCHNSIYEQSCE | 581 | Q9C0A0 | |
| RSDHYNCVSSGGQCL | 31 | P60022 | |
| YGVFLCIDCSGVHRS | 41 | Q8N6H7 | |
| NSLGSFRCHCQAGYT | 2381 | Q75N90 | |
| GRRCEHSTDCTYGRD | 331 | Q5VUD6 | |
| CSSQCGQGYRTLDIH | 916 | P59510 | |
| VYNCSGEACRGHNRS | 501 | P54802 | |
| YCGIHLISGSRDTTC | 2451 | Q6ZS30 | |
| QCRVCGDSSSGKHYG | 46 | Q9Y5X4 | |
| CLNGGTCHMLSRDTY | 76 | Q7Z3S9 | |
| GGQCHDSESSSYVCV | 3856 | P98160 | |
| YTCICGSGENSAVLH | 241 | P12955 | |
| GTYCCQAGQDSTHTR | 1876 | O75147 | |
| NDYLCVCRSAFTGRH | 1286 | Q04721 | |
| RSHACGYSNSSGCGR | 276 | Q5D862 | |
| HGGTCHNEVGSYRCV | 191 | P46531 | |
| CSARSCSAAGQVYEH | 216 | Q86XX4 | |
| VLRAAYSTGGCLHTC | 296 | Q86VZ4 | |
| VYGTCSQTCRNTHGS | 161 | Q9NZR2 | |
| RGNSRRTCACAHGYL | 2161 | Q9NZR2 | |
| RTCACAHGYLAEDGV | 2166 | Q9NZR2 | |
| PSYSGERCEVNHCSN | 4241 | Q9NZR2 | |
| GCEHICVNDRSGSYH | 316 | O15232 | |
| VIGRQCTRCATGHYG | 1291 | Q16787 | |
| DGRLLVSCHSDGSYC | 241 | Q6P1M3 | |
| SCQHGVYGRLVCTDF | 66 | Q9C0I1 | |
| TTRAGGCGHDECDTY | 56 | Q9Y219 | |
| LSSAVYTHGCGCVRS | 81 | Q8TAV5 | |
| YTHGCGCVRSATNIT | 86 | Q8TAV5 | |
| GCKCVGSQVHYARSE | 271 | Q9BZM3 | |
| VHSTCGDCVGAADAY | 551 | Q9Y4D7 | |
| RLACATAQHYGIAGC | 31 | O00628 | |
| QCSVHAECRDYATGF | 396 | P14543 | |
| NSSHSVCDEGAIGYC | 436 | Q9Y4A8 | |
| AYHSGDACLAAGCSV | 791 | O96028 | |
| NEIRTCDRHGCGQYS | 31 | O14960 | |
| TGGYAALINLCCRHD | 711 | P42704 | |
| GHTGYLSCCRFLDDN | 141 | P62879 | |
| GHTGYLSCCRFLDDS | 141 | Q9HAV0 | |
| YHTTDGTGGCISARC | 1291 | P98088 | |
| LCGNDGVTYSSACHL | 206 | P19883 | |
| HGYGCRTLVVCEGQA | 1336 | O15230 | |
| AHVIGRDCSRCATGY | 1461 | O15230 | |
| NCSSSDRYHGAQCTV | 1226 | Q13219 | |
| DRYHGAQCTVSCRTG | 1231 | Q13219 | |
| CTNYLLQEGHTSGCL | 71 | Q9HC73 | |
| GICRYGAQCTSAHSQ | 191 | P42694 | |
| CLNGGTCHMLSRDTY | 76 | P0DPK4 | |
| DRRFEQAIHYCTGTC | 21 | Q06190 | |
| ENKYCGLGRHCVTSR | 66 | Q8N475 | |
| IVIHCSAGTGRTGCY | 1081 | Q92729 | |
| CGPTLHRVCGENSYS | 106 | Q13349 | |
| HRVCGENSYSKGSCL | 111 | Q13349 | |
| NVCSRCYGGNLVSIH | 126 | Q9Y2Y8 | |
| IGHTCINTEGSYTCQ | 321 | P23142 | |
| CGRGYHLNEEGTRCV | 341 | P23142 | |
| CLCAYHGSEECSRGA | 671 | Q4G163 | |
| CGACTEDGTFRQYVH | 881 | Q9BXP8 | |
| SCTGSHLRSVCIYGA | 381 | Q9P109 | |
| SRELAGHTGYLSCCR | 136 | P62873 | |
| GHTGYLSCCRFLDDN | 141 | P62873 | |
| SLICSCDYDGGSVHI | 226 | P01133 | |
| CTGCVSRRFYHLAND | 96 | Q8NCQ5 | |
| GGVCHNTEGSYRCEC | 1126 | P35555 | |
| VCKHGQCINTDGSYR | 2136 | P35555 | |
| LTDRGYSHSCCISQH | 566 | Q6V1X1 | |
| GHRTTYTECCCQDGE | 1601 | Q14767 | |
| SFQCQCLSGYHLSRD | 806 | Q9NS15 | |
| RCQHGECANTRGGYT | 366 | Q8N2S1 | |
| ACEGGRCVNTVGSYH | 1306 | Q8N2S1 | |
| AQSCCYSRHGGVNSS | 331 | Q5SQI0 | |
| YCNVCREALSGVTSH | 176 | Q16760 | |
| FDSLSCSRVCGHYTQ | 126 | Q6UWM5 | |
| DTGQCLCLSYVTGAH | 471 | A4D0S4 | |
| ELYRSTGHGGHCTNC | 356 | P11047 | |
| GGHSVCVDLRVCFSY | 541 | Q13683 | |
| GTGNPAHLRYCVTCE | 296 | Q9NVP4 | |
| CHARDGSILAGSCLY | 116 | O75462 | |
| STGYEEIEGSCHACR | 266 | Q9UF33 | |
| AGSFQCSCEAGYRLH | 431 | O75095 | |
| YCNPLGSIHDRCNGS | 421 | Q9Y2I2 | |
| RATGLHYGIISCEGC | 66 | Q15406 | |
| LYCSQSGHFTRDCLA | 281 | Q6ZR62 | |
| EGTCQRGDQCCYSHS | 611 | Q9NXH9 | |
| GGCEQYCSDHTGTKR | 156 | P08709 | |
| SCRCHEGYSLLADGV | 171 | P08709 | |
| EVTGPRAHSCYNGCL | 66 | Q8N2H9 | |
| GTYHTDCNCFRSIDL | 551 | Q16819 | |
| CISGHAFFYTGERCQ | 696 | Q16819 | |
| GGDFRYVTCAIHNCS | 316 | Q96PQ0 | |
| AIANTRTHTYECRGC | 1126 | P30876 | |
| DYHRTCSYSCSVQGA | 881 | Q9ULL8 | |
| EHFTCESCRIGSYQD | 1011 | Q4LDE5 | |
| GYTGSRCEADHNECL | 466 | Q99466 | |
| VNCYRCGESGHLARE | 156 | P62633 | |
| TLQCTACGHRRGYSS | 201 | P57727 | |
| VMCCGRGYDTSHVTR | 306 | P09544 | |
| YVCGECGHAFSARRS | 451 | P15622 | |
| RVHTGEGAYQCSECG | 381 | Q6P9A3 | |
| VHAGVRSYICSECNR | 511 | Q05516 | |
| SCRSGFTYVLHEGEC | 2476 | P04275 | |
| VDCYAQRRLSGGSHS | 326 | Q13905 | |
| LCSICGQSFRHGSSY | 576 | Q5SVQ8 | |
| QRSHTGEKLYGCSVC | 261 | Q9BSK1 | |
| NSERCRCTLYGHTDS | 466 | Q8N0X2 | |
| HESYCGSRTELCQGC | 101 | Q6GPH4 | |
| TGCRFHVLNYFTCGE | 171 | Q7Z340 | |
| QRGHTGERPYECSQC | 606 | Q7Z340 | |
| LHRTGCSSYCGQEAE | 301 | Q9Y2I9 | |
| RTHTGDKLYTCNQCG | 341 | P21506 | |
| SLRCYRTHGTCAENF | 31 | Q9UHR6 | |
| QRVHTGERSYDCSEC | 326 | Q9HCX3 | |
| TCVLASRGFSCGRHY | 336 | Q86XT4 | |
| VSGYCHCADSQGREL | 231 | P01266 | |
| CGRSFNCSSSFRYHG | 511 | Q8N7K0 | |
| RQSGGSYLDAECSRH | 281 | Q6IEG0 | |
| ECGTVFRNYSCLARH | 586 | Q6ZNA1 | |
| KIHTGERQYACSECG | 411 | Q9Y473 | |
| HTGERSYICTQCGQA | 436 | P51508 | |
| RTHSGERPYACTQCG | 401 | O60304 | |
| RTHTGERSYNCDNCG | 361 | Q9UK12 | |
| ECGKTFCSGYQLTRH | 491 | Q8N7M2 | |
| IYGCHAQGAATCTAS | 1531 | Q9Y493 | |
| SVSCGEGYHSRQVTC | 1496 | P82987 | |
| RKRTATHTCSYAGCG | 266 | Q9Y5W3 | |
| VQCTCHTGYRLTEDG | 376 | O75096 |